The Health of Canadians – The Federal Role

Interim Report

Volume Two: Current Trends and Future Challenges

The Standing Senate Committee on Social Affairs, Science and Technology

Chair: The Honourable Michael J.L. Kirby
Deputy Chair: The Honourable Marjory LeBreton

January 2002


TABLE OF CONTENTS

ORDER OF REFERENCE

SENATORS

INTRODUCTION

CHAPTER ONE:
The Impact of Population Aging on the Health Care System.

1.1 Population Aging
1.2 The Impact of Population Aging 
1.3 Caring for Canadian Seniors
    1.3.1 Providing a Continuum of Care
    1.3.2 Primary Care Reform 
    1.3.3 Wellness Promotion and Illness Prevention 
    1.3.4 New Methods of Funding
    1.3.5 Public Policy: Long-Term Horizon 
    1.3.6 A Unique Approach to Residential Long-Term Care
1.4 Committee Commentary

CHAPTER TWO: 
Spending On Drugs In Canada

2.1 Trends in Spending on Drugs
2.2 Cost Drivers
    2.2.1 Trends in Drug Utilization
    2.2.2 Trends in Drug Prices
    2.2.3 Trends in the Types of Drugs Prescribed
    2.2.4 Cost Driver Analysis
2.3 Appropriate Drug Therapy
2.4 Who Pays for Drugs in Canada?
2.5 Do Some Canadians Have Better Coverage for Drug Costs than Others?
2.6 Committee Commentary

CHAPTER THREE:
Health Care Technology

3.1 Availability Of Health Care Technology
3.2 Health Care Technology Assessment
3.3 Impact On Health Care Costs
3.4 Committee Commentary

CHAPTER FOUR:
Disease Trends

4.1 Trends In Diseases
    4.1.1 Infectious Diseases
    4.1.2 Chronic Diseases
    4.1.3 Injury
    4.1.4 Mental Illness 
    4.1.5 The Economic Burden of Disease
4.2 Determinants of Poor or Good Health
4.3 The Need For Health Promotion And Disease Prevention
4.4 Population Health Strategy
4.5 Research
4.6 Committee Commentary

CHAPTER FIVE:
The Health of Aboriginal Canadians

5.1 Demographic Profile of Canada’s Aboriginal Population
5.2 Socio-economic Profile and Physical Environment
5.3 Health Profile of the Aboriginal Population
5.4 Federal Programs Directed to Aboriginal Health 
5.5 Aboriginal Health Policy at the Federal Level
5.6 Barriers to Aboriginal Health and Wellness
5.7 Committee Commentary

CHAPTER SIX:
Human Resources 

6.1 Physicians
    6.1.1 Physician Supply
    6.1.2 Geographic Maldistribution
    6.1.3 Physician Training and Recruitment
    6.1.4 The “Brain Drain”
6.2 Nurses
    6.2.1 Supply of Nurses
    6.2.2 Working Conditions
    6.2.3 Training and Recruitment in Nursing
6.3 Other Health Care Providers
6.4 Primary Care Reform 
6.5 Committee Commentary

CHAPTER SEVEN:
Health Research 

7.1 Federal Role in Health Research
7.2 Genetics and Genomics
7.3 Benefits and Challenges of Health Research
7.4 Committee Commentary 

CHAPTER EIGHT:
Health-Related Information: A Canadian Health Infostructure 

8.1 Concepts and Definitions
8.2 Provincial and Federal Initiatives With Respect to a Pan-Canadian Health Infostructure
8.3 Costs and Benefits
8.4 Issues
8.5 Committee Commentary 

CHAPTER NINE:
Home Care 

9.1 What is Home Care?
9.2 Current Demand for Home Care
    9.2.1 Hospital Bed Reductions
    9.2.2 Rapid Population Growth over 65 Years of Age
    9.2.3 Pressures on Informal Caregivers
    9.2.4 Advances in Technology 
9.3 Public and Private Spending
9.4 Future Actions
    9.4.1 National Standards
    9.4.2 Human Resources
    9.4.3 Organization and Financing
    9.4.4 Informal Caregivers
    9.4.5 Information and Research
    9.4.6 Prescription Drugs
    9.4.7 Telehealth
9.5 Committee Commentary 

CHAPTER TEN:
Rural Health 

10.1 Health Status Indicators
10.2 Access to Health Services in Remote and Rural Areas
10.3 Telehealth
10.4 Rural Health Research
10.5 The Federal Role
10.6 Committee Commentary 

CHAPTER ELEVEN:
Myths And Realities 

11.1 Demographic Aging
11.2 Spending on Drugs
11.3 Health Care Technology
11.4 Aboriginal Health
11.5 Human Resources in Health Care
11.6 Health Information Systems
11.7 Home Care
11.8 Rural Health

CONCLUSION 

APPENDIX: 
List of Witnesses (March – June 2001)


ORDER OF REFERENCE

Extract from the Journals of the Senate of March 1, 2001:

Resuming debate on the motion of the Honourable Senator LeBreton, seconded by the Honourable Senator Kinsella:

That the Standing Senate Committee on Social Affairs, Science and Technology be authorized to examine and report upon the state of the health care system in Canada. In particular, the Committee shall be authorized to examine:

(a)    The fundamental principles on which Canada’s publicly funded health care system is based;

(b)   The historical development of Canada’s health care system;

(c)    Health care systems in foreign jurisdictions;

(d)   The pressures on and constraints of Canada’s health care system; and

(e)    The role of the federal government in Canada’s health care system;

That the papers and evidence received and taken on the subject and the work accomplished during the Second Session of the Thirty-sixth Parliament be referred to the Committee;

That the Committee submit its final report no later than June 30, 2002; and

That the Committee be permitted, notwithstanding usual practices, to deposit any report with the Clerk of the Senate, if the Senate is not then sitting; and that the report be deemed to have been tabled in the Chamber.

After debate,

The question being put on the motion, it was adopted.

ATTEST : 

Paul C. Bélisle
Clerk of the Senate



SENATORS

The following Senators have participated in the study on the state of the health care system of the Standing Senate Committee on Social Affairs, Science and Technology:

The Honourable Michael J.L. Kirby, Chair of the Committee
The Honourable Marjory LeBreton, Deputy Chair of the Committee 

and 

The Honourable Senators:

Catherine S. Callbeck
Joan Cook
Jane Cordy 
Joyce Fairbairn, P.C.
Alasdair B. Graham, P.C.
Wilbert Keon
Yves Morin
Lucie Pépin
Douglas Roche
Brenda Robertson 

Ex-officio members of the Committee:

The Honourable Senators: Sharon Carstairs P.C. (or Fernand Robichaud, P.C.) and John Lynch-Staunton (or Noel A. Kinsella) 

Other Senators who have participated from time to time on this study:

The Honourable Senators Banks, Beaudoin, Cohen*, DeWare*, Ferretti Barth, Grafstein, Hubley, Joyal P.C., Milne, Losier-Cool, Rompkey, and Tunney 

*retired from the Senate


INTRODUCTION

In December 1999, during the Second Session of the Thirty-Sixth Parliament, the Standing Senate Committee on Social Affairs, Science and Technology received a mandate from the Senate to study the state of the Canadian health care system and to examine the evolving role of the federal government in this area.  The Senate renewed the mandate of the Committee in the First Session of the Thirty-Seventh Parliament. The terms of reference adopted for the purpose of this study read as follows:

That the Standing Senate Committee on Social Affairs, Science and Technology be authorized to examine and report upon the state of the health care system in Canada. In particular, the Committee shall be authorized to examine:


a) The fundamental principles on which Canada’s publicly funded health care system is based;
b) The historical development of Canada’s health care system;
c) Publicly funded health care systems in foreign jurisdictions;
d) The pressures on and constraints of Canada’s health care system;
e) The role of the federal government in Canada’s health care system.

[1]

 

In response to this broad and complex mandate, in March 2001, the Committee re-launched its multi-year and multi-faceted study comprising five major phases.  Table 1 provides information on each individual phase and their respective timeframes.

TABLE 1
HEALTH CARE STUDY:
INDIVIDUAL PHASES AND PROPOSED TIMEFRAMES

Phases

Content

Timing (reports)

One

Historical Background and Overview

March 2001

Two

Future Trends, Their Causes and Impact on Health Care Costs

Winter 2002

Three

Models and Practices in Other Countries

Winter 2002

Four

Development of Issues and Options Paper

September 2001

Five

Hearings on Issues and Options Paper and Development of Final Report and Recommendations

Fall 2001/Winter 2002

 

The Phase One report was released in March 2001.  The first report recounted the history of how the federal government helped the provinces and territories to fund hospital and physician care. It focused in particular on the initial objectives of the federal government’s involvement in health care and raised some questions about the future role of the federal government in light of the changing health care environment (e.g., increased recourse to drug therapy, hospital out-patient services, home care and community care). This first report also traced the evolution of health care spending and health indicators over the past several decades.  Finally, it looked at a number of myths that are still current concerning the delivery and financing of health care in Canada and clarified the reality surrounding each of these myths.  The objective of the first report was to provide factual information as well as to clarify the major current misconceptions that recur in the health care debate in Canada.

The purpose of this report is to present the evidence obtained in the second phase of the Standing Senate Committee’s study on health care.  The objectives of Phase Two were to examine the factors that can affect the affordability and sustainability of Medicare such as:

·        The aging of the population and the increased demand that will be placed on the system if past and present patterns of use continue;

·        Our growing Aboriginal population and its specific health care needs;

·        Advances in health care technology, including drugs, that affect the organization, provision and cost of health care

·        The appearance of new diseases and the resurgence of “old” ones that may require costly therapy and treatment;

·        The growing concern about the workload, stress and aging of our health care providers;

·        Particular health care issues in rural and remote areas;

·        The need for sufficient and comparable health-related information to make decisions in allocating resources and in delivering care;

·        The role of preventive interventions in encouraging healthy lifestyles and thereby enhancing the potential for better health.

In order to meet the objectives of Phase Two, the Committee heard from a wide range of witnesses, including: officials from Health Canada the Department of Indian and Northern Affairs the Canadian Institutes of Health Research and the Canadian Coordinating Office for Health Technology Assessment; officials from provincial ministries of health; health care organizations; Aboriginal representatives; and health economists (a list of witnesses in provided in Appendix A).  We are most grateful for their invaluable contribution.

This report consists of eleven chapters.  Chapter One discusses demographic trends and forecasts and examines the various implications of population aging on the health care system.  Chapter Two reviews past and current trends in drug costs and provides some information on the problem of inappropriate prescribing and utilization of drugs.  Chapter Three summarizes the concerns about the availability, cost-effectiveness and appropriateness of both new and existing health care technologies.  Chapter Four examines trends in disease and injury and discusses their potential impact on the publicly-funded health care system.  Chapter Five looks at the specific health and health care needs of Aboriginal Canadians.  Chapter Six deals with issues related to the supply, retention and management of human resources in health care.  Chapter Seven provides information on the level of funding for health research in Canada and on the future of health research in terms of its implications on health and health care.  Chapter Eight provides information on the current stage in the development of the Canadian Health Infostructure.  Chapter Nine reviews the provision of home care in Canada.  Chapter Ten examines the health care needs of rural Canada.  Chapter Eleven discusses myths and realities in an attempt to clarify many of the misconceptions in order to ensure an informed, fact-based debate on health care.


CHAPTER ONE:

The Impact of Population Aging on
the Health Care System

1.1     Population Aging

Demographic aging refers to the increasing average age in a society, and is characterized by the emergence of a greater proportion of older people in the overall population.  From a historical perspective, the process of population aging in a given country is determined primarily by fertility (birth) rates and secondarily by mortality (death) rates.  It can also be affected by the rate of immigration.  Over the 20th century, various advances – public sanitation, medical breakthroughs such as vaccination, and technological enhancements – have increased life expectancy while fertility rates have declined markedly.  The net result has been longer life expectancies and an aging population.

Canada’s population is aging.  The proportion of Canadians aged 65 and over more than doubled between 1881 and 1981, rising from 4.1 percent to 9.7 percent.[2]  Since then, the percentage of the population aged 65 and over has increased steadily, to reach 12.5 percent of the population in 2000.[3]  

Text Box: I look at the aging of the population as one of the great successes of the health and social services systems.

Dr. Michael Gordon, National Advisory Council on Aging (2:36)

Demographic aging is expected to intensify in the coming decades, as the “baby-boomer generation” gets older.  The baby-boomers are those Canadians who were born between 1946 and 1965, a period during which the number of births soared.  According to recent projections by Statistics Canada, the proportion of seniors (those aged 65 and over) will reach 14.6% of the population by 2010 and then grow more rapidly as increasing numbers of baby-boomers reach retirement age.  By 2031 they are expected to represent 23.6 percent of the population.[4]  The rate of increase will then subsequently slow down, and seniors should constitute about 25% of the population by 2051.

Witnesses told the Committee that the cut-off point used to identify “seniors” (those over 65) continues to be used exclusively for historical reasons rather than scientific ones.  As Abby Hoffman, Director General of the Health Care Directorate at the Health Policy and Communications Branch of Health Canada, said, “We use it because it is the agreed legal age for certain purposes of retirement, but it has no use other than that.”[5]  More importantly, the category “over 65” is not at all a homogeneous one.  There are many differences amongst seniors that depend on factors such as gender, socio-economic status, place of residence, or ethnic background.

Many demographers stress the need to distinguish between younger and older seniors, noting, for example, that the prevalence of institutionalization does not really begin to increase until age 75.  At the same time, however, according to Professor Byron Spencer of McMaster University, “roughly speaking, the ‘old old’ make somewhat less use per capita of physician services – of specialized services in particular – than do people in the ‘younger old’ ages.”[6]  The proportion of people aged 85 and over within the senior population has been increasing over the years.  According to Statistics Canada, it will continue to do so, although not uninterruptedly, as the pattern depends on the aging of the baby-boomers.  The proportion of those over 85 is expected to reach 21% of all seniors by the time all the baby-boomers have reached that age in 2051.

 

1.2     The Impact of Population Aging

As Graph 1.1 shows, health care costs follow a pattern that varies with age.  They tend to be relatively high in the earliest years, fall significantly during youth and young adulthood, rise gradually during middle age and then sharply increase during old age.  On average, per capita public spending on health care for those aged 65 and over is almost five times greater than per capita spending on the rest of the population.  Growth in health care spending in the older age groups is exponential: spending more than doubles from ages 45-64 to ages 65-74; it doubles again from ages 65-74 to ages 75-84; and it doubles once again from the 75-84 age group to the 85 and over age group.

Given this pattern, both the growing number of seniors and the fact they will make up a larger percentage of the population raise many concerns for the future sustainability of Canada’s health care system.  There remains, however, a considerable degree of disagreement among Canadian experts as to the impact that an aging population will have on overall health care costs.  A review of the literature points to at least four different plausible scenarios:[7]

(a)          The “nightmare high-cost” scenario.  This scenario assumes that, while people live longer, they still get sick or become disabled at the same age as now.  Thus, health care costs continue to rise at the same rate as over the past two decades.  The combined effects of these two trends (population aging and increased costs) leads to a doubling of the percentage of GDP devoted to health care spending.  The “crisis” is further compounded by the fact that a smaller percentage of the population is working and contributing to the public purse.

(b)   The “compressed morbidity” scenario.  This scenario supposes that people will live longer without disability or disease, meaning that overall health care costs will not rise as sharply as the more pessimistic scenarios envisage.

(c)          The “manageable costs” scenario.  The onset of disability and disease is postponed to the same extent as death itself, while rising costs in health care are offset by budgetary cuts elsewhere.

(d)          The “reformed system” scenario.  Significant changes to the delivery of health care result in greater efficiencies that will allow the system to cope with the added pressure of an aging population.

Witnesses who testified before the Committee reflected these various views.  For example, the Conference Board of Canada contended that health care will consume an increasing proportion of government expenditures in the coming years as a result of population aging.  The Board estimates that, by 2020 in both British Columbia and Ontario health care expenditures will represent about 50 percent of total provincial government spending (compared to 38 and 36 percent, respectively, in 2000).[8]  Similarly, William Robson, Vice-President and Director of Research at the C.D. Howe Institute, calculated that if the provinces and territories continue to tax the same share of their gross domestic products as they do at present, health spending in Newfoundland, the Yukon, and the Northwest Territories could require fully 100% of their own-source revenue by 2040.[9]

Dr. Michael Gordon, of the National Advisory Council on Aging (NACA), stressed that, in attempting to gauge the impact of an aging population on health care spending, we should be careful not to make unwarranted assumptions about the state of health of seniors in the future.  Nor should we simply assume that the current level of efficiency of the health care system will prevail.  To illustrate this point, he stated in his brief to the Committee that, “if we were to extrapolate the length of hospital stays for seniors in 1999 based on data from 1971, the result would be 50% higher than the actual numbers.”[10]

For his part, Professor Byron Spencer pointed out that population aging takes place slowly; this means that there is still time to develop appropriate public policy responses.  He also noted that “the ratio of the total population to the population of working age is low today, by historical standards, and it will not change much for another fifteen or twenty years.”[11]  This ratio, known as the “dependency ratio,” is used as a rough indicator of the ability of the population to support itself.  It usually compares the number of people who are of working age (20 to 64) to those who have either not yet entered the workforce (0 to 19) or who are no longer working (65 and over).  This dependency ratio in Canada reached a peak in the middle of the 1960s, as a result of the high proportion of young dependants (the baby-boomers).  Since then, the ratio has declined substantially.

Some analysts suggest that the declining trend in the dependency ratio is misleading since the ‘dependant’ population is now more heavily concentrated amongst seniors, who are heavier users of health care, than amongst the dependent young.[12]  For this reason, William Robson told the Committee:

The broad directions are clear.  In the coming decades, the older population, who are more intense users of health services, will grow quickly. The younger working population, who participate in the workforce and generate government tax revenue, will grow relatively slowly or even shrink.[13]

Professor Spencer presented a strong case to the Committee suggesting that the increases in health care spending that will occur as the population ages could very well be balanced by decreases in other areas of government expenditures that will also come about as a result of population aging.  He pointed out to the Committee that:

It is important to note that if you are concerned about the overall impact of population aging, it makes little sense to focus on one area in which costs will go up and say there is a crisis, without also focusing on other areas in which costs will not go up or may even go down. For example, the residents of penal institutions are mostly young. In that area there would be noticeable cost savings. Older people do not receive Employment Insurance, yet that is a very large component of government expenditures, et cetera.[14]

And, he concluded that:

If we consolidate all of the different categories of expenditure, not just the areas where there is an age-related potential crisis, the impact is, in a series of progressions, that government expenditure increases in consequence of population change and the aging of the population at very much the same rate as the population as a whole. Government expenditures would increase approximately 50 per cent over that period, while the population increases 50 per cent over that same projection period.[15]

According to Professor Spencer, the challenge we are facing is therefore one of properly allocating the resources that are available to governments rather than an absolute shortage of resources.

Assessing the impact of an aging population on health care costs also requires an understanding of how best to meet the health and health care needs of that population.  Jean-Marie Berthelot from the Health Analysis and Modelling Group of Statistics Canada indicated to the Committee that “the health of the current generation of 45 to 64 year olds is better than that of the same category twenty years ago.”[16]  Moreover, this generation “has a higher level of education, has smoked less and is comprised of more individuals with employment income (mainly because of higher labour market participation by women) than the previous generations.”[17]

New indicators to measure how much of our lives are spent in good health have been developed, including dependence-free life expectancy (DFLE) and health-adjusted life expectancy (HALE). Different levels of dependency (summarized in Table 1.1) have been identified that require different types of assistance and entail varying levels of cost for the health care system.  If most of tomorrow’s seniors will spend their additional years of life in relatively good health (the ‘compressed morbidity’ hypothesis), then the impact of aging will be considerably smaller than if longer life expectancy is associated with a correspondingly longer period of illness (the ‘expanded morbidity’ hypothesis).  In this regard, Mr. Berthelot explained:

Between 1986 and 1996, years of dependence-free life expectancy at age 65 increased significantly, from 12.0 to 12.7 and from 12.7 to 13.5 for men and women respectively. By contrast, there was little change in life expectancy with dependence. Thus, the proportion of dependence-free lives increased.[18]

He also pointed out that there was no clear correlation between the amount different countries spend on health care and the age profile of their population.  In their brief, Statistics Canada noted that “the United States spends close to 14% of its GDP on health care but the proportion of seniors in its population is less than 13%, whereas Sweden spends less than 9% of its GDP on health care, even though its proportion of seniors is 17%” of the population, and that, nonetheless, “life expectancy of Swedes at 65 years of age is higher than that of Americans.”[19]

 

TABLE 1.1

NEW HEALTH STATUS INDICATORS

Level

Health Status

Definition

1

Dependence-free

No dependency or needs help only with heavy housework

2

Moderately dependent

Needs help for meal preparation or for shopping for groceries or other necessities or for everyday housework

3

Severely dependent

Needs help for personal care or for moving around the house

4

Institutionalized

Lives in a health care institution

Source: Martel, Laurent and Alain Bélanger, “An Analysis of the Change in Dependence-Free Life Expectancy in Canada Between 1986 and 1996,” in Statistics Canada, Report on the Demographic Situation in Canada, 1999, p. 171.

Another important issue raised to the Committee concerns whether the increased health care costs associated with an aging population are due to aging per se, or whether they can be more plausibly attributed to the costs of dying.  As Rob Brown, from the Task Force on Health Care Financing of the Canadian Institute of Actuaries, told the Committee:

We expend something in the order of 50 per cent to 70 per cent of the final year health care costs just prior to death. In fact, there are estimates that up to 50 per cent of our total lifetime health care expenditures may be made just prior to death.[20]

This was also the general picture painted by Abby Hoffman who noted that, “the extremes of relative expenditure on the old and the young are more attributable to the proximity of death than they are to the simple fact of being older.”[21]

While this assessment can help identify more precisely the causes of increased health care spending generated by having more older people, it does not lead to any easy policy prescriptions.  Dr. Michael Gordon put this point pithily to the Committee:

I would like to note that if we could only get rid of the last year of life, we would save a lot of money. The problem is that the last year is only known afterwards. (...) One does not decide to forego surgery, as I went through with my father last week, and who is 89, because one may die from it. It is done because the person is vibrant and needs the surgery. Should he die in three weeks, one might say that that was a waste of money, but that is not the way we provide health care. We do not look from the back; we always look forward, fortunately.[22]

A number of witnesses stressed that while the aging of the population will be one of the important drivers of cost increases to health care over the coming decades, it is not the only one, and probably is not even the most important one.  Health Canada identified the following factors driving changes in health care spending:

·        Population aging

·        Fiscal capacity

·        Technology and innovation

·        Factors affecting need and demand for health services (including population health status, preferences and values)

·        Changes in the structure of health care delivery systems

·        Relative costs of health care compared to general price inflation

Against this background, Health Canada’s projections anticipate that although population aging will account for an increasing percentage of the growth in health care expenditures in the period from 2001-2030, it will still represent under 30% of the total projected growth, as shown in Graph 1.2.[23]

1.3     Caring for Canadian Seniors

1.3.1   Providing a Continuum of Care

According to Dr. Michael Gordon of NACA, a key dimension of meeting the needs of Canadian seniors, now and in the future, is “to develop and more fully integrate”[24] the various health care components into a continuum of care that would encompass wellness promotion, illness and injury prevention, acute hospital care, medical care, home care, long-term care and palliative care.  There are, however, many challenges associated with the development of such a continuum, embracing issues such as what services should be covered by the publicly-funded system, how these should be delivered in an integrated fashion, and how to ensure that there is an adequate supply of health care providers to meet the variety of needs.

Professor Spencer stressed to the Committee the importance of an integrated approach:

I would like to emphasize the importance of an overall, integrated look at the health care system as a system, so that substitution of one type of personnel for another, or the question of care in hospitals versus in the community, and all the rest of it are also considered. That is very important. There is much scope for saving costs by moving towards best practice, where that is being demonstrated repeatedly in all sorts of studies. There are better ways of doing things, yet we seem to have a system that does not readily accommodate this information as it becomes available.[25]

The idea of a more integrated approach to health care delivery in order to meet the needs of an aging population brought forward the suggestion from several witnesses that health services provided in the home and prescription drugs should be covered under the Canada Health Act.  For his part, Dr. Gordon proposed that home care for the elderly be publicly covered:

…home care should now be part of the health care system. The Canada Health Act, when constructed, had a rather limited view of health care, which at the time was perhaps appropriate. However, much of health care can now be delivered in the home. Many of the problems related to aging and function, rather than requiring high-tech treatments, require relatively low cost, but very important assistance in home care. We believe that this should become part of the health care system.[26]

With respect to prescription drugs, the Committee was told that, although all provinces provide public coverage to seniors, the nature and scope of this coverage vary widely, as drugs prescribed for use outside the hospital setting are not under the umbrella of the Canada Health Act.  More importantly, Dr. Gordon stated that despite public coverage for prescription drugs, Canadian seniors may still face financial hardship: “the funding systems in some provinces require that, for a very modest increase in your income, your costs of Pharmacare escalate rapidly.” (The issues regarding prescription drugs and home care are discussed in more detail in chapters Two and Nine respectively.)

Finally, witnesses stressed the importance of providing appropriate palliative care: “it is important to have a comprehensive palliative care system that is institutional or home-based – whatever is appropriate for the individual –  and that the time has come to ensure that all Canadians who require palliative care have access to it.”[27]

 

1.3.2   Primary Care Reform

Text Box: If I were a family physician, I would put my office up three flights of stairs with no elevator.  They cannot possibly provide good care to the elderly, or they would be making less than the checker at Loblaws.

Dr. William Dalziel, University of Ottawa (3:19)

It is clear from the testimony presented to the Committee that the current fee-for-service system has serious drawbacks with regard to providing even current levels of care to the elderly.  Geriatric practice, as NACA indicated, requires time and health care and professional resources that are less readily provided when physicians’ sole source of income is fee-for-service payment.  In this regard, Dr. William Dalziel, of the University of Ottawa, stated:

I can run a middle-aged person through my office, usually with a simple problem, without dealing with a backdrop of five other problems and taking six drugs, in 15 or 20 minutes. The average consultation for a senior would take an hour to an hour and half. In most provinces, you are paid exactly the same amount for each patient.[28]

These kinds of prospects have a major impact on the recruitment of geriatric specialists.  Dr. Dalziel noted that, “I have residents coming to me to ask why they should do two more years’ training in geriatrics so that they can earn 30 to 50 per cent less money.”[29]  Only seven physicians are expected to enter programs in Canada to become geriatric specialists this year.  Four of these are in Quebec, leaving only three for the rest of the country.  Dr. Dalziel estimated that there is already a shortage of approximately 500 specialists in the field.

The issue of physician remuneration is part of the much broader discussion about primary care reform (see Chapter Six).  Primary care reform also provides possible avenues for developing a more integrated approach to the provision of the full continuum of care, which is of great relevance to the health care needs of seniors.  This implies that a broader range of health services is available at this level, that a wider range of health care providers is available and that services are delivered in the most cost-effective manner.  Overall, primary care reform that allows these different skills to be more effectively teamed together allows seniors (and others) to have better access to the health services they need, when they need them.

 

1.3.3   Wellness Promotion and Illness Prevention

The importance of health promotion and disease prevention is another point that was made by several witnesses.  Dr. William Dalziel stated categorically that “the key to staying healthy is exercise” and gave the following example:

Elderly women training two times a week for six months were made five years younger in terms of heart and lung capacity. Over an eight-week strength training program for women in their 90s living in nursing homes, it was found that they increased their quadricep muscle strength by 174 per cent. People stopped falling. They threw away canes and walkers.[30]

Data provided by Health Canada (see Graph 1.3) show that falls are amongst the most important preventable causes of death amongst seniors, leading to more than double the rate of mortality per 100,000 population than motor vehicle crashes, homicides and suicides combined.  Despite the real possibility that expenditure on health promotion and disease and injury prevention would improve the quality of life for many seniors, and save the system money, NACA expressed concern that federal investments in health promotion programs had dwindled throughout the 1990s.

Text Box: Our conclusion is that there are resources to be saved by the application of good prevention and health promotion measures.  That is one reason to pursue them, but the most important reason is to have a healthier population for as long as life lasts for the individuals in question.

Abby Hoffman
Health Canada (7:23)

 

1.3.4   New Methods of Funding

Perhaps the most important issue that specifically touches on the aging population has to do with health care financing. It was generally agreed that, at least until the peak of the baby-boom generation has died, there would be important cost pressures placed on the system that could be directly attributed to the aging of the population.  This raises the question as to how any additional costs should be covered.

Witnesses suggested that there is an issue of inter-generational fairness that needs to be taken into account in this regard.  Our health care system is basically funded on a pay-as- you go basis.  That is, revenues are collected from people who currently pay taxes, and these pay for government services to everyone, including those who are no longer paying taxes, or paying less than they did while working.  As the proportion of seniors increases, however, there will be proportionally fewer people of working age to cover the (growing) costs of health care for the aging population.  The burden on the working population could thus be expected to increase, resulting in what some see as an unfair transfer of wealth from one generation to another.

One way of dealing with this problem is to develop a pre-funding mechanism that would allow future expenses to be paid for by the people who would actually make use of them.  This was the intent of the proposal put to the Committee by William Robson of the C. D. Howe Institute.  More precisely, he suggested that part of the current Canada Health and Social Transfer (CHST) from the federal government to the provinces and territories be converted into a “senior’s health grant.”  He explained:

…we could replace part of the CHST with a new grant, set at $3,000 per senior, and initially offset the grant with matching decreases elsewhere so that it is cost-neutral in the first year. Over time, we would allow the grant to escalate at the same rate per capita as other grants relative to the general population, but being geared to the seniors' population, it would grow more quickly. In that way, you could accommodate some of the demographic pressure on the federal transfers.[31]

Another method of pre-funding that was brought to the Committee’s attention was the proposal from the Clair Commission in Quebec for a special “loss-of-autonomy fund” that would be financed through employer and employee contributions. Similar to a dedicated pension fund, it could be managed by an arms-length body that would ensure its financial viability and that its resources be used to help finance a broader range of services for the aging population.

 

1.3.5   Public Policy: Long-Term Horizon

Finally, several witnesses raised the issue of the need for longer-term overall policy planning with regard to the needs of the aging population.  Professor Byron Spencer noted, for example, that at one time the Economic Council of Canada provided medium- to longer-term economic projections and analysis, and that it might be useful to consider setting up an agency that would have as its focus, in particular, “the anticipation of the effects of population aging.”[32]  This could strengthen our ability to regularly study the economic implications of demographic change and their fiscal and budgetary consequences for government.

 

1.3.6   A Unique Approach to Residential Long-Term Care

During the course of its study, the Committee received interesting information on Laurier House.  Situated in Edmonton (Alberta), Laurier House could be described as “condo care”: residents buy their own suites; receive on-site constant medical care; pay a monthly fee for operating costs, food and domestic services; and when they die, their estate receives back most of the capital investment.  Laurier House is operated by the Capital Care Group, the largest publicly funded and operated continuing care organization in the country.

Laurier House has 78 suites occupied by 100 people.  One-bedroom suites cost $97,000-$115,000; two-bedrooms $118,000-$136,000; studios $88,000.  The monthly fee for residents, depending on their accommodation, varies from $950 to $1,060.  Health services are funded by Alberta Health.  Laurier House differs from standard nursing homes in that residents buy their suite; the provincial government does not put any money into capital costs.

 

1.4     Committee Commentary

The Committee acknowledges that there remains a considerable degree of disagreement among experts as to the impact that an aging population will have on the sustainability of the health care system.  These differing views can be summarized into four different scenarios:  the “nightmare high-cost” scenario, the “compressed morbidity” scenario, the “manageable costs” scenario, and the “reformed system” scenario.

Of these scenarios, the Committee feels that the least likely to be realized is the first one, the “nightmare high-cost” scenario.  The evidence it heard suggests that while the aging population, especially during the peak of the baby-boom, will put important pressures on the health care system, these are unlikely to result, in and of themselves, in a full-blown crisis.

Indeed, the aging of the population is only one of a complex mix of factors – related to both supply and demand – that contributes to the increase in health care costs.  Other cost drivers include the use of new technology, the cost of new drugs, changing patients’ expectations, and so on.

This does not mean, however, that nothing needs to be done to help cope effectively with the pressures associated with demographic aging.  The Committee believes that it is important to study carefully the various proposals for ‘pre-funding’ the costs associated with an aging population, at least until the full effects of the baby-boom generation have been felt.  Moreover, we feel that the aging population increases the urgency of addressing a number of other issues, and may require that specific measures be adopted within broader programs of change.

For example, primary care reform that would not be organized exclusively on a fee-for-service basis and would therefore build in incentives for physicians to spend more time consulting with patients, has particular importance for seniors who often represent more complex cases.  Primary care reform could also allow a wider range of services to be available at the initial point of contact with the health care system, something that is also of great interest to seniors who require care from a number of health professionals.  This implies, however, that the issue of expanding public coverage to include these services also be addressed.  And, in this context, it is necessary to explore whether other services, such as home care and prescription drugs, should also come under the provisions of the Canada Health Act.

While primary care reform and expansion of public coverage, as well as issues related to the implementation of an integrated continuum of care, are of great relevance to the health of seniors, they also have many implications for the broader population.  In Phase Four of its study, the Committee will examine these issues in more detail.

Finally, the Committee found Laurier House to be a rather unique and striking concept.  Of course, the question may be raised as to whether Laurier House is a form of “two-tier” nursing care system.  We suggest that it may represent a two-tier housing system for the ill, but that it still remains within a one-tier health care system.



CHAPTER TWO:

Spending On Drugs In Canada

The term “drugs” (or “medicines”) typically includes prescription drugs, non-prescription drugs (over-the-counter or OTC products) and personal health supplies.  Prescription drugs are usually prescribed by a physician or dentist, dispensed by pharmacists, and received either in hospital or in the community. OTC products such as cough and cold remedies and pain relievers can be purchased without a prescription through a number of retail outlets.  Personal health supplies such as oral hygiene products and home diagnostic kits are also available to the public through retail outlets.

Drugs can be patented or non-patented.  A patented drug is one for which a patent has been issued.  Non-patented drugs include drugs that are not yet patented, drugs whose patents have expired, drugs for which there has never been a patent and generic copies.  Since 1987, the Patented Medicine Prices Review Board (PMPRB) has regulated the prices charged by manufacturers of patented drugs in Canada.  There are two components to this price regulation.  One is a limit on increases to the costs of patented drugs already on the market; the other is a limit on introductory prices of new patented drugs.  The prices of non-patented drugs are not subject to regulation.

Health Canada is responsible for the approval of all drugs that enter the Canadian market.  It assesses new drugs to ensure that they are safe to use and are effective in treating what they claim to treat.  Authorization to market or distribute a medicine is granted through a Notice of Compliance (NOC).  However, a drug may be distributed with specified restrictions before receiving a NOC, as an Investigational New Drug or under the Special Access Program (SAP).

Witnesses pointed out that drug therapy is an integral part of health care.  The importance of drugs in treating disease, maintaining health and quality of life, and in preventing and reducing the need for surgery and hospital stays is well recognized.  The Committee was told that appropriate drug therapy can optimize health outcomes and avoid other unnecessary costs.

Text Box: Drugs continue to consume an increasing share of Canada’s health care dollar, accounting for the second largest category of health expenditures next to hospital services.  In 2000, spending on drugs is expected to have reached $14.7 billion, representing 15.5% of total health care spending, following increases of 8.9% and 9% in 1999 and 2000.

CIHI (2001)

 

2.1     Trends in Spending on Drugs

Data reported by the Canadian Institute for Health Information (CIHI) indicate that spending on drugs in Canada has grown continually over the past 25 years, from $1.1 billion in 1975 to $14.7 billion in 2000.[33]  During this period, drugs accounted for an increasing portion of total health care spending: in 1975, drugs represented about 9% of total health care expenditures; by 2000, this share had increased to almost 16% (see Graph 2.1).  Data from CIHI also suggest that total spending on drugs has been growing at a higher rate than inflation.  Furthermore, since 1997, expenditures on drugs have been the second largest category of health care spending in Canada, behind hospitals but ahead of spending on physician services.

Graph 2.2 shows that spending on drugs in Canada, expressed in dollars per capita, continues to increase at a rate faster than spending in other key health care sectors such as hospitals and physicians.  In fact, between 1990 and 2000, drug expenditures per capita increased by almost 93%, more than twice the average for all health care expenditures (40%).

Four components generally make up the cost of prescription drug products.  These are: the manufacturer’s price, the wholesaler’s mark-up, the retailer’s mark-up and the pharmacist’s dispensing fee.  Data from IMS Health (Canada) and the Federal/Provincial/Territorial Task Force on Pharmaceutical Prices estimated that, in 1997, wholesale and retail mark-ups and dispensing fees accounted for just over one-third of the end cost of a prescription drug while distribution costs and the manufacturer’s selling price comprised 4% and 63% respectively of the final cost.[34]

Prescription drugs make up the largest component of spending on drugs (77% in 2000, up from 72% in 1975).  Non-prescription drugs and personal health supplies accounted for the remaining 23% of drug spending in 2000 (compared to 28% in 1975).  For the most part, non-prescription drugs and personal health supplies are purchased directly by consumers and paid for out-of-pocket.  By contrast, multiple payers are involved in the financing of prescription drugs.  In 1975, the private sector accounted for 80% of prescription drugs expenditures.  By 2000, private sector spending had decreased to 57%.  During the same period, the share of prescription drugs financed from public sources increased steadily from 20% in 1975 to 43% in 2000.

More drugs are being sold in Canada every year, and patented drugs comprise an ever-growing proportion of drug sales.  According to the Patented Medicine Prices Review Board (PMPRB), total sales by manufacturers of pharmaceuticals for human use in 2000 in Canada are estimated at $10.0 billion.  This represents an increase of 12.4% from 1999.[35]  The total sales of patented drugs as a proportion of total drug sales have been steadily rising.  At 43.9% of sales in 1995, by 2000, patented drugs comprised 63.0% of total sales.[36] From 1990 to 1995, sales of non-patented brand name drugs accounted for nearly 50% of the total drug sales of companies holding drug patents.  From 1996 to 2000, however, that proportion declined steadily, reaching 28% in 2000.[37]  At the same time, generic drug sales have been increasing.  According to information published by IMS Health and reported by the PMPRB, total sales of generic drugs are estimated at approximately $929 million in 2000, an increase of 15.2% from 1999.[38]

Most patented drugs are sold by prescription.  Of the patented drug products reported to the PMPRB for human use, about 96% required a prescription.[39]  The quantity of patented drugs sold has also increased.  From 1988 to 2000, the average annual increase in quantities of patented medicines sold was 12%.  This compares with an average annual increase in their prices of 0.8%.[40]

Overall, increases in spending on drugs in recent years have had an important impact on escalating health care costs.  According to witnesses, this trend is likely to continue as Canada’s population ages, new drug therapies become available, and demand for prescription drugs increases:

Drugs will become more and more effective and will constitute an increasing portion of the therapies utilized and their share of health care costs will continue to rise. New drugs are expensive, but they will be prescribed and access will be demanded by an aging public that is increasingly aware of its options (…).[41]

 

2.2     Cost Drivers

A number of factors are contributing to increased drug spending including: increased levels of drug utilization, price increases and greater use of costlier, newer drugs.  Some of these factors may have a greater impact on spending than others.

2.2.1   Trends in Drug Utilization

Drug utilization refers to the quantity of drugs used.  Increases in the number of prescriptions can relate to a number of factors including: population increases; changes in the age structure and health status of the population; increases in the number of people being prescribed a particular drug; trends toward using drug therapy instead of other forms of treatment; new diseases and better treatment of existing diseases; and increases in the number of prescriptions per person.

More prescriptions are being written in Canada every year.  IMS Health (Canada) reports that approximately 272 million prescriptions were dispensed in 1999, up by 6.3% over 1998.  This gives an indication of the magnitude of drug utilization in Canada – an average of 8.9 prescriptions per person per year, up from 8.3 in 1998 (see Table 2.1).

TABLE 2.1

UTILIZATION OF PRESCRIPTIONS IN 1999

 

Average family size

Prescriptions per person

Prescriptions per family

Average prescription price

Consumption per family/year

3.1

8.9

28.0

$35.48

$978.89

Source:  IMS Health (Canada).

 

There is much to learn and understand about drug utilization in Canada.  Utilization is increasing, but at the same time utilization patterns for various drugs can differ across Canada and between Canada and other countries.  There are significant variations in the use of some drug therapies across the country.  Benzodiazepines are one example.  Many more benzodiazepines are dispensed in Eastern Canada than in Western Canada: in 2000, 41.5 tablets and capsules of benzodiazapines were dispensed per capita from retail pharmacies in New Brunswick, a number that is more than three times the per capita rate in Saskatchewan.  Significant variations also exist within provinces.  Benzodiazepines’ usage in northern Alberta, for example, is higher than in southern Alberta.[42]

Text Box: There is a significant variation in the utilization of pharmaceuticals that does not correlate to population distribution.

Dr Roger A. Korman (4:15)

 

Dr. Roger A. Korman, President of IMS Health (Canada), told the Committee that although a causal link has not yet been established between use of benzodiazepines and socio-economic status, there seems to be a correlation – usage is higher in lower socio-economic status areas.[43]  Use of benzodiazepines also correlates more closely to the age of the prescribing physician than to the age of the patient – 90% of the top 100 prescribers of benzodiazepines in Alberta, Quebec and Ontario graduated from medical school before 1981.[44]

Utilization of various drugs can vary from country to country.  Although utilization of antibiotics is decreasing in Canada, it is still twice as high as utilization in the Netherlands.  Ritalin is another example.  Canadian prescriptions for Ritalin continue to grow at a rapid pace (9% in 2000), but are down by 5% in the United States.

2.2.2   Trends in Drug Prices

Both the federal and provincial governments have roles in controlling Canadian drug prices.  At the federal level, the PMPRB reviews prices charged by the manufacturers of patented drugs to ensure that they are not excessive.  In addition, provincial and territorial governments have used a number of approaches to manage drug prices in their Pharmacare plans. These include:[45]

·        Generic substitution – where a generic drug is available, the lower-priced generic product must be substituted for the equivalent brand name drug, unless a physician otherwise orders.

·        Formulary management – this could include not listing drug products on formularies, listing with restrictions or de-listing.

·        Reference-based pricing – paying for the lowest price drug in a therapeutic group.  The main difference between reference-based pricing and generic substitution is that under the former, drugs in a category have only to be therapeutically equivalent, not chemically identical.

·        Controls on mark-ups and dispensing fees - provincial governments can limit markups on drugs and dispensing fees paid to pharmacists.

·        Risk-sharing – in some cases, governments have negotiated with drug companies to limit total expenditures on specific drugs.  If expenditures exceed an agreed-upon level, the company pays the province for expenditures above that amount.

·        Price freezes – Ontario introduced a price freeze from 1994 to 1998.

The PMPRB limits annual price increases of patented drugs to the increases in the Consumer Price Index (CPI).  With the exception of one year (1992), prices for patented drugs have not increased more than the CPI since 1988.  In 2000, the prices of patented drugs rose by an average of 0.4% while consumer prices increased by 2.7%.[46]  The PMPRB also reviews the introductory prices of new patented drugs.  Generally, prices for most new patented drugs are limited so that the cost of the new drugs will not be greater than the highest cost of therapy for existing drugs used to treat the same disease.  The price of a new breakthrough drug is limited to the median price for the drug in seven other countries – France, Germany, Italy, Sweden, Switzerland, the United Kingdom and the United States.  Furthermore, the price of a patented drug cannot exceed the highest price in these countries.[47]

In 1987, Canadian prices for patented medicines were some 23% higher than median international prices.  By the mid-1990s, Canadian prices were about 10% below such prices; in 2000, they were 8% below median international prices. The PMPRB reported that Canadian prices were slightly lower than prices in Germany, Sweden, Switzerland and the United Kingdom but higher than prices in France and Italy.  Prices in the U.S. were higher than all other countries.[48]

The F/P/T Task Force on Pharmaceutical Prices analyzed annual price changes of prescription drug products in six provincial drug plans.  The study divided drug products into three categories: patented drugs; non-patented single source drugs; and non-patented multiple source (brand name and generic) drugs.  In 1997, spending on patented drugs comprised about 50% of the total prescription spending in the six drug plans.  Non-patented single source drugs made up 13% of the total amount spent by the plans on drugs in 1996.  The Task Force compared the Canadian and foreign prices of the top-selling non-patented single source drugs reimbursed by the six drug plans and found that Canadian prices were, on average, 30% higher than the median international prices of the seven countries used by the PMPRB for comparative purposes.  These prices contrast with Canadian prices for patented medicines, which were about 10% lower than median foreign prices.[49]

Multiple source drugs (brand-name and generic) accounted for 44% of prescription drug plan spending of five of the provincial plans in 1997.[50]  Data from the F/P/T Task Force on Pharmaceutical Prices indicate a clear trend toward higher generic drug prices in relation to their brand name equivalents.[51]  According to the Task Force, “this trend has occurred despite the fact that overall prices of generic drugs have remained stable or declined, and prices of their brand name equivalents have remained constant or increased during this period.”[52]  Two possible explanations for this are: higher relative introductory prices for generic drugs; and differences in price trends for generic drugs with no brand name equivalent than for generics with brand name counterparts.[53]  A study by the Fraser Institute (August 2000) also showed that generic drug prices were often higher in Canada than in the United States.[54]

Drug prices vary from province to province.  The F/P/T Task Force on Pharmaceutical Prices reported significant differences in the manufacturers’ prices across Canada for the same drug products.  In 1993, prices in Ontario, the highest price province, were 8.8% higher than the prices in British Columbia, the lowest price province.  By 1997, the last year covered by the report, price differences had been reduced, with Nova Scotia, the highest price province, having prices that were 5% higher than the lowest price province, Manitoba.  The Task Force also found that if all provinces in the study had paid the lowest available prices for the same products in 1997, $60 million would have been saved.[55]

2.2.3   Trends in the Types of Drugs Prescribed

A shift in prescribing patterns away from older therapies toward newer costlier drugs can have a significant impact on drug spending.  Data compiled by the F/P/T Task Force on Pharmaceutical Prices reveal that in 1997, newer drugs (introduced since 1990) represented 57% of the total pharmaceutical expenditures in British Columbia.  The introduction and use of new drugs was estimated to have been responsible for 32% of the increase in drug spending in British Columbia between 1990 and 1997.

2.2.4   Cost Driver Analysis

Using data from British Columbia, the F/P/T Task Force on Drug Utilization found that changes in prescription drug spending could be attributed to the following cost drivers (see Graph 2.3):  price increases of existing drugs (18%), increased utilization of existing drugs (50%), and sales of new drugs in their first full year (32%). In 1997, drugs introduced on the Canadian market since 1990 (newer drugs) accounted for 57% of pharmacare expenditures in British Columbia.  As a result of these findings, the Task Force concluded that increased drug utilization and increased consumption of newer drugs were the primary drivers of prescription drug spending.[56]

2.3     Appropriate Drug Therapy

Appropriate drug therapy refers to prescribing and utilizing the right drug at the right time.  Appropriate and cost-effective utilization of drugs is essential if we are to both optimize health outcomes and avoid unnecessary health care costs.  There are, however, two major barriers to appropriate drug therapy:  inappropriate use by patients and inappropriate prescribing by physicians.  Table 2.2 provides a brief outline of inappropriate use and inappropriate prescribing.

Inappropriate prescription drug use is a problem of increasing significance.  Estimates put patient non-compliance with prescribed drug regimes and early discontinuance of medications for chronic conditions such as high blood pressure and high cholesterol as high as 50%.  Using Saskatchewan data with respect to patient use of cholesterol-lowering drugs, Dr. Robert Coambs, President and CEO of Health Promotion Research, pointed out that it takes 18 months to two years before the benefits of such drugs are realized, but only 10 percent of patients are still using their medication after 800 days.  Non-compliance can lead to other adverse health situations, as well as increased visits to physicians and hospitals.[57]  Patients often fail to take the medication as prescribed, stop taking their medication too soon, or neglect to refill prescriptions.

  Text Box: Every chronic care medication has severe compliance problems.

Dr. Robert Coambs (4:8)

 

 

TABLE 2.2

INAPPROPRIATE DRUG THERAPY:  DEFINITION

INAPPROPRIATE DRUG USE1

INAPPROPRIATE PRESCRIBING2

·        Not having a prescription filled or refilled

·        Taking too much or too little of the drug prescribed

·        Erratic dosing, such as altering time intervals or omitting doses

·        Stopping the drug too soon

·        Taking a drug without a prescription

·        Combining prescription drugs with OTC products or illicit drugs

·        Combining prescription drugs with alcohol

·        Under-prescribing or not specifying sufficient quantities or correct intervals of doses

·        Over-prescribing or going beyond the maximum therapeutic dosage

·        Prolonged use that result in iatrogenic effects and adverse reactions

·        Prescribing that is contraindicated by the medical condition

·        Contraindicated combinations that produced an undesirable effect

      1Coambs, Robert B., Ph.D. et al., Review of the Scientific Literature on the Prevalence, Consequences, and Health Costs of Non-Compliance and Inappropriate Use of Prescription Medications in Canada, PMAC, 1995.

2Coambs, Robert B., Ph. D., et al., A Preliminary Review of the Causes of Inappropriate Prescribing and its Costs in Canada.  Health Promotion Research, February 1997.

Research also reveals that many patients do not understand their drug therapy.  The Committee heard that half of all patients who walk out of a physician’s office do not understand the drug they were given, why they were given it, or how they were supposed to take it.[58]  Low levels of literacy are a major barrier to the appropriate use of prescription drugs.

Inappropriate prescribing of medications is also a problem, particularly in relation to seniors.  The Canadian Association of Gerontology discussed the problem in a recent policy statement:

Seniors are more likely to receive prescriptions for medication that are potentially inappropriate; 11% to 46% of seniors receive at least one inappropriate prescription per year. (…) Prescribing errors account for approximately 19% to 36% of drug-related hospital admissions.  The co-existence of multiple prescribing physicians, the number of drugs currently in the market (over 24,000), the number of relative contraindications documented (over 33,000) and deficiencies in physician knowledge related to both age and training are important contributors to the risk of inappropriate prescriptions.[59]

 

TABLE 2.3

ESTIMATED ECONOMIC COSTS
OF INAPPROPRIATE DRUG THERAPY

(In Billions of Dollars)

 

INAPPROPRIATE USE

INAPPROPRIATE PRESCRIBING

Direct Costs:

§         Hospitals

§         Nursing Homes

§         Ambulatory Care

 

1.78 – 2.74

0.66

1.09

 

0.30 – 0.85

0.12 – 0.43

Indirect Costs:

§         Lost Productivity and Premature Deaths

 

 

3.5 – 4.49

 

 

0.42 – 1.28

Total Economic Costs

7.06 – 8.98

0.84 – 2.56

Source:  as in Table 2.2.

Inappropriate prescription drug use costs the health care system substantial amounts of money.  A 1995 study by Dr. Coambs et al. showed that the economic costs of inappropriate prescription drug use in Canada was between $7 to $9 billion annually, an amount equivalent to the cost of cancer, from all causes, in Canada.[60]  This figure incorporated both direct costs – resulting from increased hospitalization, more medical visits and interventions, and higher nursing home costs; and indirect costs – resulting from lost productivity at work, absenteeism, and premature deaths.  In 1997, Coambs and his team evaluated the economic costs of inappropriate prescribing as ranging between $0.8 and $2.6 billion annually (see Table 2.3).

Text Box: Pharmacists make substantial contributions to primary health care every day by fixing patients' drug-related problems, improving patient compliance – the problem identified in the earlier presentation – managing minor illnesses, and promoting good health. However, it is also a fact that the knowledge and skills of pharmacists are underutilized (…).

Dr. Jeff Poston, CPA (4:10)

 

Witnesses stressed that improving the quality of drug use would have a positive impact on patient health and on spending.  Dr. Coambs suggested that good patient support programs would help ensure that patients were taking medication properly.  Dr. Jeffrey Poston, Executive Director of the Canadian Pharmacists Association, emphasized the role of pharmacists in creating value for money in drug use.

While drug use management strategies such as trial prescription programs can save money, the greatest improvement in value for money comes when pharmacists sit down with patients and critically review their therapy.  In a recent study in Ontario, pharmacists reviewed the medication of elderly patients on five drugs or more. Eighty-eight percent of those patients had, on average, 3.23 drug-related problems.  The pharmacist informed the physician taking care of the patient about these problems, and in 69 per cent of cases, the physician accepted recommendations from the pharmacist to make changes.[61]

Dr. Poston urged that pharmacists be an integral part of primary care reform.  This would solve the problem of underutilizing pharmacists and would also enhance overall drug therapy:

(…) as provinces develop primary health care reform, they should look at ways to integrate pharmacists into the proposed models for primary health care delivery. Such models should be designed to make maximum use of the consultative services pharmacists can provide to optimize drug therapy.[62]

Witnesses also commented on the importance of using information to reduce waste resulting from inappropriate prescribing and use of drugs.  The Committee heard that Canada lacks comprehensive drug use and cost information.  Evaluating the quality of drug use was seen as a priority.  Ms. Barbara Ouellet, Director, Home Care and Pharmaceuticals Division (Health Canada), pointed out that:

Canada does not have good, comprehensive drug use and cost information, which in and of itself is a barrier to any analysis, including analysis of some of the policy directions or potential implications of policy directions. Canadians are also seeking authoritative, evidence-based, patient-oriented information provided when their prescriptions are written or dispensed.[63]

Dr. Poston called for research that critically evaluates the quality of drug use:

There has been a strong focus on drug costs, but little on the quality of drug use.  It is through improving the quality of drug use that true savings will be found, both in costs and human life.  Evaluation research should focus on the value of interventions developed to improve the quality of drug use.[64]

 

2.4     Who Pays for Drugs in Canada?

Most Canadians have some form of insurance coverage for prescription drugs from one source or another.  They receive drug coverage from government programs, private plans through their employers, and individual plans (see Table 2.4).  Information provided to the Committee by the Canadian Life and Health Insurance Association (CLHIA) suggests that about 97% of the Canadian population is protected by some form of prescription drug insurance.  Estimates by the CLHIA also show that:

·        employer-sponsored group plans are the primary source of insurance for Canadians, providing coverage to 57% of the population;

·        individual drug insurance companies cover another 3% of the population;

·        the two major public prescription drug insurance plans for seniors and social assistance recipients contribute 12% and 10% respectively to the total;

·        provincial programs for the general population (i.e. not limited to seniors or social assistance recipients) cover another 15% of the population;

·        programs for status Indians and eligible Inuit and Innu account for about 2% of the coverage;

·        various other plans (individual policies, affinity groups, etc.) account for a further 1%;

·        some 3% of the Canadian population appear to have no insurance coverage at all for prescription drugs.[65]

 

TABLE 2.4

TYPES OF PLANS

PRIVATE PLANS

GOVERNMENT PLANS

§         Employment benefit plans

§         Individual insurance policies

§         Affinity-related group plans

§         Registered Indians, eligible Inuit and Innu

§         Veterans

§         Seniors

§         Social assistance recipients

§         Institutionalized individuals (health related and Corrections)

§         Universal programs open to all residents

Source:  Canadians’ Access to Insurance for Prescription Medicines, Executive Summary, Applied Management in Association with Fraser Group Trisat Resources, Study submitted to Health Canada under the Health Transition Fund, March 2000.

Because the Canada Health Act does not include prescription drugs used outside the hospital setting, public coverage varies considerably from province to province.  Similarly, private insurance for prescription drugs provided through employer-sponsored plans or individual insurance companies exhibit significant differences in terms of design, eligibility and out-of-pocket costs.

For example, there are wide variations in public prescription drugs insurance plans:[66]

·        The federal government provides drug plan benefits to registered Indians and eligible Inuit and Innu under the Non-Insured Health Benefits program for medication not covered by provincial or territorial government plans.

·        Veterans Affairs Canada provides drug plan coverage for certain eligible veterans.

·        Members of the armed forces and their families receive drug coverage from the federal government, as do prisoners in federal correctional institutions.  Provincial governments provide drugs to prisoners in provincial institutions.

·        Some provinces have universal programs (British Columbia, Saskatchewan and Manitoba cover all residents; Quebec covers residents without employer-sponsored drug plans; Ontario has an income-tested program to cover individuals with high drug costs relative to income).

·        All provinces and territories cover social assistance recipients and seniors under Pharmacare programs although some provide coverage to low-income seniors only.

·        Individuals with certain high-cost diseases are covered in all provinces (for example, people with diabetes, HIV/AIDS, cancer, cystic fibrosis).

·        Nursing home and long-term care facility residents obtain drug benefits through provincial drug plans or through funding for the operation of the home or facility.

·        Some provincial drug plans charge premiums. Most do not. Others have deductibles (an amount that individuals must pay before being eligible for reimbursement).  Most provincial government plans require plan beneficiaries to pay a portion of the prescription costs after the deductible is reached (co-payment).  Many plans limit the total amount individuals are required to pay in co-payments and deductibles.

·        Provincial and territorial drug plans have adopted formularies – a list of drugs that the plan will pay for.

Most large employers and many small employers offer employee benefit plans that include drug coverage.  A number of the larger employers also cover retirees.  Self-employed individuals can also purchase individual drug plan coverage.  Employers usually pay the premium costs under most employer-sponsored plans but employees may also be required to contribute: the split between plans requiring employees to pay a premium and those that do not is about 50/50.  Many private plans do not have deductibles and those that do impose relatively low deductible amounts.  Beneficiary co-payments are a feature of many private plans (usually 20%), but a number of plans make no provision for co-payments.

The public/private mix of prescription drug coverage varies widely across Canada.  Data from IMS Health (Canada) shows that public insurance covers only 31% of the cost of prescription drugs in Newfoundland and New Brunswick, while governments are responsible for over 60% of prescription drug costs in Saskatchewan, Quebec and Manitoba (see Table 2.5).  Overall, residents of the Atlantic Provinces have less public coverage for prescription drugs than residents of other parts of Canada.

 

TABLE 2.5

WHO PAYS FOR PRESCRIPTION DRUGS

JURISDICTION

GOVERNMENT PERCENTAGE

CASH/PRIVATE SECTOR PERCENTAGE

British Colombia

40.9%

59.1%

Alberta

45.5%

54.5%

Saskatchewan

66.1%

33.9%

Manitoba

62.2%

37.8%

Ontario

42.8%

57.2%

Quebec

62.2%

39.8%

New Brunswick

31.1%

68.9%

Nova Scotia

33.3%

66.7%

Newfoundland

31.1%

68.9%

Source IMS Health (Canada)

 

2.5     Do Some Canadians Have Better Coverage for Drug Costs than Others?

The Health Transition Fund (Health Canada) funded a study to examine the range and extent of government and private prescription drug plans and to assess measures of under-insurance in Canada.  A copy of this comprehensive study, which is entitled Canadians’ Access to Insurance for Prescription Medicines, was provided to the Committee.[67] 

Perhaps the most striking conclusions from the study are the substantial regional variations in who is eligible for coverage and the reimbursement levels under government drug plans.  The study also reveals that a substantial number of people have inadequate coverage or no coverage at all.  Part-time and low-income workers are particularly vulnerable because they do not qualify for government plan coverage and do not have access to an employee benefits plan.  Overall, the study came to the following conclusions:[68]

·        Ninety-three percent of Canadians have a combination of public and private drug insurance plans to provide protection against serious financial hardship in the event that expensive drug treatment is required.  Approximately
4 percent of the population would be considered under-insured because their coverage would reimburse only a portion of their bills while 3 percent are uninsured.

·        Residents of the Atlantic Provinces, other than seniors and social assistance recipients and those in employer-sponsored group programs have no protection against catastrophic levels of drug expense.

·        In all provinces, except Quebec, workers in part-time or low-wage positions are more likely to be uninsured or underinsured for routine drug expenses compared to the general population under age 65 because there is little to no coverage under employer-sponsored group plans.

·        In all provinces, except Quebec, there is reduced coverage in the 55-64 age group.

·        Of the Aboriginal population, registered Indians or eligible Inuit and Innu have good coverage under Health Canada’s Non-Insured Health Benefits program.  Métis and Non Status Indians, on the other hand, are more likely to be under-insured or uninsured than the non-Aboriginal population.

·        Therefore, the strongest determinant of whether an individual will have adequate coverage against catastrophic (high) drug expenses is province of residence.  While many individuals, especially seniors, have protection against catastrophic expenses under government plans, non-seniors residing in provinces or territories without universal government programs can face a significant financial burden if they do not have private drug plan coverage through their employers.

Another study that was tabled before the Committee assessed the recent changes to the Quebec prescription drug plan and the effect of co-payment on drug consumption.[69]  In 1996, Quebec made drug insurance mandatory.  As a result, previously uninsured individuals were given access to a prescription drug plan.  The new drug plan required beneficiaries to pay a portion of their prescription costs.  This differed from the previous plan under which many beneficiaries – particularly social security recipients and seniors entitled to the Guaranteed Income Supplement – received prescription drugs free.  The Quebec study found that seniors and social security recipients significantly reduced their drug consumption.  This decline in consumption applied to both essential and non-essential drugs.  The study also reported increases in the number of adverse events, emergency room visits, and visits to doctors attributable to the reduction in consumption of essential drugs.[70]

Text Box: Two-tier health care is alive and well. First estimates vary, but approximately 
3 million Canadians have no drug coverage, and probably another 3 million or more have inadequate coverage because of the high deductibles and co-payments that were introduced in many public plans in the 1990s. 

Dr. Jeffrey Poston (4:12)

A number of witnesses raised concern about patient access to drug therapy especially in light of recent changes to public drugs plans that impose higher co-payments and deductibles.  In their view, if certain patients have to bear all or a portion of the cost of their prescriptions, they will forego essential drug therapy. They stressed that many Canadians have inadequate drug coverage or no coverage at all and cannot afford the drugs prescribed for them.  This, of course, has important cost and service implications for other areas of the health care system.  For example, Dr. Coambs observed:

(…) if you raise the price or make the drug less accessible, people will fill scrips less, renew the scrips less, and use other health care resources more. They will drive up your hospitalization charges if you deny them the drugs. …Economics is a barrier and other access issues are also a barrier.[71]

A number of witnesses recommended that the federal government develop, in collaboration with the provinces, a national Pharmacare plan.  There is no single model for a pan-Canadian Pharmacare, and a number of complex issues can influence their design.  These include deciding who should be covered (e.g., everyone, specific groups of the population such as seniors or social assistance recipients, etc.), what is covered (e.g., all prescriptions, specific categories of prescriptions, etc.), and how it should be financed (e.g., public financing only or a mix of public and private funding with deductibles, co-payments, etc.).  Witnesses indicated that if user charges were required under Pharmacare, they should be minimal; they should not place an undue burden on patients.

Furthermore, there is considerable controversy concerning the costs of setting up a national Pharmacare program and of ensuring its long-term viability.  In 1997, Palmer d’Angelo Consulting Inc. estimated the cost of funding several models of national Pharmacare.  Here is a summary of the major findings of this study:

·        A fully funded, comprehensive, publicly administered, national Pharmacare plan would increase public expenditures on prescription drugs by an estimated $4.3 billion.

·        Other publicly administered plans would increase public expenditures by $2.1-$2.5 billion with patients paying co-payments or the dispensing fee.  These plans would in essence “nationalize” current private plans.

·        With a national Pharmacare plan similar to the drug plans that exist in Saskatchewan and Manitoba, public expenditures would fall by almost $0.5 billion.  However, expenditures by individuals would increase by $0.9 billion.

·        The impact on the public purse of the mixed public/private plans is considerably less than the public only plans.  The incremental increase in expenditures range from $0.1 billion with a plan similar to that currently in Quebec, to $1.5 billion for a plan that provides true first dollar coverage.[72]

Clearly, the cost of funding a national Pharmacare program would vary according to how it is designed.  A recent study by Dr. Joel Lexchin suggested that although such a system would increase public spending, it would nonetheless save money by reducing administrative costs and dispensing fees.[73]  The impact of a national Pharmacare program on drug prices is also unclear.  For example, international experience with national Pharmacare programs shows that drug costs continue to grow at a rate of 8% annually.

The Committee was told that the idea of a common drug formulary was being discussed at the provincial and territorial level.  More specifically, following their conference in August 2000, Provincial Premiers and Territorial Leaders agreed to work together and “mandated their Health Ministers to develop strategies for assessing and evaluating prescription drugs.  These strategies could include the creation of a common inter-provincial/territorial advisory process to assess drugs for potential inclusion in provincial/territorial drug plans.”[74]  However, the Committee was told that provinces might resist the development of a national drug formulary:

With respect to Pharmacare, a fairly broad proposal was made to governments in the early 1990s that included aspects of what we are talking about here, including national formularies. The issue for the provinces is that they are trying to manage their own resources in ways that best meet the needs of their own populations. That may mean, for example, that if they have a high senior population, then there will be certain demands for access to pharmaceuticals for that population. If they have a high proportion of AIDS patients, then they will need to deal with those needs as well. They are desperately trying to ensure that the drugs they list are appropriate for their citizens. In fact, as some drugs lose their effectiveness and better ones become available, can they actually be removed from the formularies? I would say that there is currently no desire or will to talk about one national formulary because of the need to respond flexibly to their own population needs, which they argue would differ.[75]

 

2.6     Committee Commentary

In recent years, there has been a marked increase in drug spending.  The evidence suggests that the growth in drug costs has been driven largely by increased utilization of drugs and a shift from older, less-expensive medications to newer, costlier forms of drug therapy, but less so by price increases.  Witnesses told the Committee that they expect drug spending to take up an even larger portion of health care dollars in the future.

There is also increasing evidence of inappropriate prescribing and use of medicines.  Patient non-compliance with prescribed drug regimens and early discontinuance of medications for chronic conditions is estimated to be as high as 50%.  Inappropriate drug therapy is costly to the Canadian health care system.  In the opinion of the Committee, it is critical to address the issue of inappropriate drug therapy.  We agree with witnesses that pharmacists can play a crucial role in primary care reform and that better integration of the work of physicians with that of pharmacists can greatly reduce the economic burden of inappropriate drug prescribing and use.  The Committee also believes that the implementation of health information systems could greatly improve information on prescribing and using medicines.  The development of PharmaNet in British Columbia, for example, deserves attention as it provide pharmacists with a complete record of drugs prescribed to each resident of the province.

Furthermore, the Committee received evidence that Canadians do not have uniform coverage for prescription drugs.  Some Canadians have no coverage at all, while others are clearly under-insured.  Lack of coverage for prescription drugs and under-coverage are of particular concern for residents of the Atlantic provinces.  The Committee strongly feels that prescription drugs should be easily available when they are medically necessary.

There is, at the moment, no definite consensus regarding the development of a national Pharmacare program.  A variety of models can be envisioned each of which raises multiple issues.  For example, should a national Pharmacare plan meet all the conditions of the Canada Health Act?  Should a national Pharmacare plan be established along with a national drug formulary or with existing individual provincial formularies?  How would the plan be financed – public funding only, public/private mix, with co-payments and deductibles?  Where would the public funding come from – general taxation, employer/employee premiums, a dedicated health care tax, etc.?

In Phase Four of its study, the Committee will outline options for addressing these various issues.


CHAPTER THREE:

Health Care Technology

Health care technology” is a very broad concept that can be defined as “the set of techniques, drugs, equipment, and procedures used by health care professionals in delivering medical care to individuals and the systems within which such care is delivered.”[76]  David Feeny, professor of Pharmacy and Pharmaceutical Sciences at the University of Alberta, told the Committee that the concept of health care technology includes both embodied and disembodied technologies.  An embodied technology is one that is “contained” or captured in the physical artefact itself.  In contrast, disembodied technologies are ideas or procedures that do not involve a tangible product or piece of equipment.[77]  Table 3.1 provides selected examples of health care technologies.

 

TABLE 3.1

EXAMPLES OF HEALTH CARE TECHNOLOGY

EMBODIED TECHNOLOGY

Devices, Equipment and Supplies:

§         Cardiac pacemakers, computed tomography (CT) scanners and magnetic resonance imagers (MRIs), surgical gloves, diagnostic test kits, etc.

Medical and Surgical Techniques:

§         Coronary angiography, gall bladder removal, etc.

Drugs:

§         Aspirin, beta-blockers, penicillin, vaccines, blood products, etc.

Support Systems:

§         Electronic patient record systems, telemedicine systems, blood banks, clinical laboratories, etc.

DISEMBODIED TECHNOLOGY

Procedures:

§         Pap smear test

Ideas:

§         Early ambulation following surgery, washing hands between patients, etc.

 

The Committee heard that health care technologies have lifecycles: some are well-established while others are in the early stages of development; still others have become obsolete.  Innovative technologies today move increasingly quickly from the research laboratory to the health care sector.  As a result, rapid innovation is contributing to faster obsolescence of health care technologies.

The Committee was also told that Canada does not play a leading role in the development of health care technology.  In fact, 70 percent of health care technologies currently used in Canada were developed abroad.

Everybody agrees that health care technology constitutes an important component of health care delivery in advanced countries.  Health care technology can improve the speed and accuracy of diagnosis, cure disease, lengthen survival, alleviate pain, facilitate rehabilitation, and maintain independence.  However, many concerns have been raised in Canada about the availability, assessment and cost of both new and existing health care technologies.  The Committee was told that these issues need to be addressed if Canadians are to derive the maximum benefits health care technology can provide, while sustaining an affordable health care system.

Although the definition of health care technology does encompass drugs, this chapter will discuss issues related to “hard” technologies only.  Issues related to drugs are the subject of the previous chapter.

 

3.1     Availability Of Health Care Technology

A recent study by the Fraser Institute shows that although Canada is the 5th highest among OECD (Organization for Economic Cooperation and Development) countries in terms of total spending on health care (as a percentage of GDP), it is generally among the bottom third of OECD countries in the availability of health care technology (see Table 3.2).  For example, Canada ranks 21st of 28 OECD countries in the availability of CT scanners, 19th of 22 in availability of lithotriptors, and 19th of 27 in availability of MRIs.  Its only favourable ranking is in the availability of radiation equipment, where it ranks 6th out of 17.  The study also reveals that this technology gap is widening.  For example, Canada’s deficit in the availability of MRIs worsened between 1986 and 1995 relative to other leading OECD countries including Australia, France, the Netherlands and the United States.  In other words, Canada’s levels of health care technology are disproportionately low given its level of health care spending.

TABLE 3.2

AVAILABILITY OF HEALTH CARE TECHNOLOGY INTERNATIONAL COMPARISONS, 1997  
(number per million population)

TECHNOLOGY

CANADA

OECD AVERAGE

CANADIAN RANK

SAMPLE SIZE

CT Scanners

8.1

12.9

21

28

Radiation Equipment

5.3

4.2

6

17

Lithotriptors

0.4

1.4

19

22

MRIs

1.7

3.9

19

27

Health Care Spending as a % of GDP

 

9.3

 

7.7

 

5

 

29

Note: Data is not available for some countries for some technologies. 
Source: David Harriman, William McArthur and Martin Zelder, “The Availability of Medical Technology in Canada: An International Comparative Study.”  Public Policy Sources, No. 28, 2000.

The Fraser Institute study also indicates that Canada lags behind its competitors in terms of the more advanced health care technology.  For example, 18 leading-edge technologies - including intraoperative CT scanners and “open” type MRIs - are available in Washington and Oregon, but unavailable in the province of British Columbia.

According to the study, the low availability of health care technology in Canada has translated into limited access to care and lengthened waiting times.  For example, waiting times for CT, MRI and ultrasound scans are relatively long and are growing.  In particular, the current waiting time for an MRI is 12 weeks and 5 weeks for a CT scan.  Overall, waiting times have grown by more than 40% since 1994.

Text Box: Many of our standard x-ray machines and other machines in the hospitals are functionally inadequate at this point because they are simply too old to do the job for which they were designed. It has become quite common to see duct tape holding our equipment together. It has become a joke amongst us. You see this in the press, but it is true. I have seen it in my own hospitals and my own area of work.

Dr. John Radomsky, president
CAR (5:7)

 

Availability is not the only issue with respect to health care technology.  The “aging” of that technology is also of concern.  For example, information provided to the Committee indicates that between 30% to 63% of imaging technology currently used in Canada is outdated (see Table 3.3).  The outdated nature of the health care technology depends on both the number of years in usage and the relative effectiveness of the equipment in terms, for example, of the quality of the image or the dose of radiation.

TABLE 3.3

OUTDATED RADIOLOGY EQUIPMENT

EQUIPMENT TYPE

PERCENTAGE OF OUTDATED EQUIPMENT

General radiography

Fluoroscopy

Ultradonography

Angiography

Mobile radiography

CT

Nuclear medicine

Mammography

MRI

63%

63%

53%

50%

50%

39%

34%

32%

30%

Source: Canadian Association of Radiologists, Timely Access to Quality Care – the Obligation of Government, the Right of Canadians, Brief to the Committee, March 2001, p. 4.

The Committee was told that the shortage of new technology and the use of outdated equipment impede exact diagnosis and inhibit high quality treatment.  This situation, which can negatively impact on the health of a patient, also raises concerns about the liability of the health care providers.  When he appeared before the Committee, Dr. John Radomsky, president of the Canadian Association of Radiologists (CAR), provided the following example:

Several machines in one of our hospitals are approximately eight to ten years old. They were once state-of-the-art machines. They are maintained to that standard. However, when I find a breast cancer with my newer ultrasound machine in the office, I cannot find that same cancer with the eight-year-old machine in the hospital. Therefore, I cannot perform a biopsy on it. We have to use some other test or send the patient to some other facility, thereby increasing the cost, the anxiety, as well as inconvenience of the patient.(…) There is the potential to miss something that will be hazardous to the patient, and that puts us in an untenable position.[78]

It is not clear why Canada is not introducing and making use of health care technologies at the same pace as other OECD countries and why it does not routinely replace aging equipment.  Indeed, many factors seem to contribute to this situation:

·        On the one hand, Canada imports most of its health care technology.  This contrasts sharply with countries such as Germany, France and the United States which have a strong health care technology industry.  It may be easier and less costly to purchase new equipment from a domestic manufacturer than from an offshore supplier.

·        On the other hand, investment in health care necessarily implies that trade-offs have to been made between health care technology and other health care goods and services.  For example, while Canada is far behind other countries in terms of the availability of “hard” technology, if we include drugs in the definition of technology, then Canada does not do so poorly.  Therefore, we might invest relatively less in health care technology, but relatively more in other health care goods and services.

·        Moreover, the process for assessing health care technology is separated from the decision-making process for purchasing such technology.  It is difficult for assessment agencies to have any influence on the purchase of health care technologies when the decisions are made at other levels of the health care system.

·        But most importantly, fiscal pressures faced by all levels of government throughout the 1990s have resulted in low levels of capital investment in Canada’s health care system.

The federal government is well aware of the deficit in health care technology.  In September 2000, it announced that it would invest a total of $1 billion in 2000-01 and 2001-02, to assist provinces and territories in the purchasing of new medical equipment.  This funding was made available upon passage of the legislation in October 2000, allowing provinces and territories to start making immediate acquisitions of necessary diagnostic and clinical equipment.  Although the medical community has welcomed this injection of new federal funds, a number of concerns remain:

·        Some provinces have not applied for their share of this fund, possibly because the federal government requires matching grants.

Text Box: The recent influx of new health care funding from the federal government has been welcomed by provincial payers, as well as those working in the system. However, it also means that it is important now, perhaps more than ever, to pay attention to how these funds are spent, by using an approach that is based on closely examining the evidence behind the many products and services competing for the public health care dollar.

CCOHTA, Brief, p. 4.

 

 

·        There is no apparent accountability within the provinces as to exactly where that money is going to be spent.

·        This funding is not distributed equitably among health care facilities.  For example, CAR told the Committee that all federal government funding in the province of Ontario is being directed toward hospitals, although approximately 50% of all radiology testing is conducted outside of the hospital sector, by community-based independent health care facilities.

·        Additional resources are required to operate the equipment.  CAR estimates that a $1 billion investment in new equipment necessitates some $700 million to cover operational costs.

·        This investment does not address the problem of the old equipment that needs to be upgraded.  According to the CAR, this would require an additional $1 billion investment.

·        This new funding does not enable Canada to rank at a level comparable to that of the other OECD countries.

·        Finally, this funding is not subject to any requirement for health care technology assessment.

The Committee was told that the aging of the Canadian population as well as increased public expectations will have a great impact on the future needs for health care technology.  Overall, witnesses suggested that the current deficit in health care technology requires a serious re-evaluation of the way in which equipment is supplied, funded and provided in Canada.  They also stressed that health care policy-makers must forecast future needs and develop an appropriate plan for action.

Text Box: As the proportion of elderly people increases, the demand for imaging procedures likely will also increase. As many diseases are more prevalent in the elderly, more medical imaging procedures, per capita, are performed on adults than on children; an on older rather than younger adults.

CAR, Brief, p. 8.

 

Witnesses underlined, however, that providing the health care sector with all the technology it needs would not solve all the problems because there is not an appropriate level of professionals to operate that equipment.  In their view, there is a need to increase the number of professionals, retain those that we have and bring back some of the people who went to the United States or other countries.  This issue is discussed in more detail in Chapter Six, which deals with the availability and distribution of human resources in health care.

 

3.2     Health Care Technology Assessment

Technology assessment refers to the production and analysis of evidence on the safety, clinical effectiveness and economic efficiency of health care technologies.  Health care technology assessment (HTA) often also considers the social, legal and ethical implications of the use of health care technologies.  HTA can be undertaken at various stages of a technology’s lifecycle.  HTA contributes in many ways to the knowledge base for improving the quality of health care: it can ensure that health care technologies are effective, that they are applied in the appropriate cases and conditions, and that the least costly technology is used to achieve a particular outcome.  Moreover, HTA can assist in deciding whether a new technology should be introduced or when an existing technology should be replaced.

Text Box: Health Technology Assessment (HTA) is the process of evaluating medical technologies (devices, equipment, procedures and drugs) and their use. HTA researchers collect, synthesize and critically evaluate the available research on medical technologies. Based on an interdisciplinary approach, an assessment can encompass analyses of safety, efficacy, effectiveness, quality of life and patient use. Other important factors such as economic, ethical, and social implications and other effects which may be unintended, indirect or delayed, may also be considered.

CCOHTA, Brief, p. 2.

In recent years, the federal and provincial governments have supported the creation of various health care technology assessment agencies.  The first provincial HTA agency in Canada was established in 1988 in Quebec – the Conseil d’évaluation des technologies de la santé du Québec.  A national agency, the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) was established in 1989.  The British Columbia Office of Health Technology Assessment was established in 1990.  The Health Technology Assessment unit of the Alberta Heritage Foundation for Medical Research was established in 1996.  Health services utilization agencies, with close links to their respective provincial governments, which undertake some HTA activities, have been formed in Manitoba, Ontario and Saskatchewan.  At the national level, CCOHTA plays a role of coordination of all HTA activities across jurisdictions, and it attempts to minimize duplication with other national and provincial organizations.

The Committee was told that, despite the work performed by these agencies, not enough attention is devoted to HTA in Canada.  On a worldwide basis, Canada spends less in HTA activities than other countries.  Dr. Jill Sanders, president and CEO of the CCOHTA, mentioned that while CCOHTA invests some $4.3 million, with some additional funding from provincial governments (about another $3 million), the United Kingdom provides some
$100 million.  Therefore, health care technologies are often introduced into Canada’s health care system with only superficial knowledge of their safety, effectiveness and cost.

David Feeny[79] told the Committee that, while the volume and scope of HTA in Canada has increased in recent years, the reports generated by the HTA agencies rely heavily upon the synthesis of existing evidence.  In his view, these agencies have lacked the resources to fund large-scale studies and, in particular, to conduct randomized controlled clinical trials.  Furthermore, the social and ethical implications of health care technologies have received relatively little attention in the work of Canadian agencies.

Professor Feeny also argued that if the goal of the health care system is to maintain and improve the health status of Canadians, then more needs to be done in assessing how health care technology can have an impact on health-related quality of life (HRQL).  He suggested that the increased use of outcome measures such as HRQL would have the potential to enhance substantially the accountability and transparency of the health care system.

Martin Zelder, Director of Health Policy Research at the Fraser Institute, suggested that Canada should use the results of HTA undertaken offshore.  Other witnesses cautioned, however, that we cannot simply translate the results of HTA studies realized elsewhere.  The application of foreign research is complicated by certain factors such as differences in demography and patterns of disease, differences in the costs of various health care resources, and differences in patterns of practice.

Text Box: If governments are not assisted with information regarding the relative safety and efficacy of competing treatment alternatives that may vary widely in cost, there is a great potential for taxpayer dollars to not be used appropriately.

CCOHTA, Brief, p. 3.

According to Dr. Radomsky, HTA in Canada remains in the realm of academia and government, and it does not filter down to the grassroots users.  In his view, health care providers need to work with experts in HTA to develop clinical practice guidelines that will allow them to use the equipment more efficiently and effectively.  Therefore, there is a need for more collaboration and multidisciplinary work.  In the same vein, Dr. Sanders suggested that decision- makers be involved in the design, execution, and interpretation of evaluative studies and HTA activities.  This would help getting the evidence gained from HTA activity into the formulation of public policy with respect to health and health care.

Overall, witnesses pointed to the importance of investing more in HTA and stressed the need to increase the awareness and thus the use of HTA findings.

 

3.3     Impact On Health Care Costs

In terms of spending and effectiveness, there are four different ways that health care technologies can have an impact on the provision of health care.  In general, a technology can be: 1) more effective and more expensive; 2) more effective and less expensive; 3) less effective and less expensive; 4) less effective and more expensive.[80]  Unfortunately, however, the Committee was told that the precise contribution of technology to the costs of health care in Canada is not known.  Attempts to quantify the connection between technology and rising health care expenditures have suffered from a lack of reliable data.  The majority of studies to date have treated technology as a “residual” item, attributing to technology that portion of the increase in health care spending not accounted for by more easily identifiable factors.[81] 

Therefore, we do not know how much Canada spends on health care technology nor do we know how health care technology has an impact on the health and quality of life of Canadians.  It is not possible to know whether the cost of health care technology represents an “add-on” or whether it is offset by reductions in the actual costs of the treatments they permit.  Witnesses unanimously pointed to the need to undertake research in this area.

 

3.4     Committee Commentary

The Committee is concerned by the shortage in health care technology and the impact this might have on waiting lines.  In our view, timely access to diagnosis and treatment is a crucial objective that must be ensured in Canada’s health care system.  In this perspective, we applaud the investment by the federal government to help the provinces and territories in the financing of new medical equipment.  It is our hope that the various concerns raised during the hearings regarding the use of these new funds be addressed in a timely manner.

Nevertheless, the Committee agrees with witnesses that technology assessment is a critical activity and that more HTA needs to be undertaken when considering the introduction of a new technology or the replacement of existing medical equipment.  The Committee is also aware that there is currently an under-production of relevant and timely information on the costs and consequences of the use of health care technologies and that more research in this area would greatly benefit the whole health care system.  The federal government, through its role in financing innovative health research, should devote more funding to the assessment of new and existing health care technologies.


CHAPTER FOUR:

Disease Trends

The 20th century revolution in health care has significantly altered the pattern of diseases, with the causes of mortality shifting away from infectious diseases and towards non-communicable diseases.  Chronic diseases, such as cancer and cardiovascular disease, are now the leading causes of death and disability in Canada, while accidental injuries are the third most common cause of death.  However, some infectious diseases once thought to have been conquered – such as tuberculosis – are re-emerging and antibiotics are becoming increasingly ineffective against them.  Rapid international transport of foods and people also increases the opportunities for the spread of infectious diseases.

The incidence of illness and trends in diseases greatly differs between men and women and within sub-populations such as Aboriginal peoples, children and youth, as well as between different socio-economic groups.  The economic burden of disease is significant and must be seen to include not only direct health care costs, but also lost productivity and lower quality of life.

There are concerns that new diseases and increasingly prevalent illnesses may have a significant impact on the current and future costs of health care.  However, many of the causes of disease, disability and early death are preventable.  It has been suggested that increasing efforts in the area of health promotion and disease prevention, with a particular focus on Canadians with low incomes and low levels of education, must remain key areas in public policy if we are to improve overall health status and contain health care costs.

 

4.1     Trends In Diseases

The leading causes of death have changed dramatically over the 20th century (see Table 4.1).  In the early 1920s, heart and kidney diseases were the leading causes of death.  The next most common causes were influenza, bronchitis and pneumonia, followed by diseases of early infancy.  Tuberculosis took more lives than cancer.  Intestinal illnesses such as gastritis, enteritis and colitis, and communicable diseases such as diphtheria, measles, whooping cough and scarlet fever, were also among the leading causes of death.

TABLE 4.1:

LEADING CAUSES OF DEATH  
(Rate per 100,000)

1921-25

Cardiovascular and renal disease

Influenza, bronchitis and pneumonia

Diseases of early infancy

Tuberculosis

Cancer

Gastritis, duodenitis, enteritis and colitis

Accidents

Communicable diseases

 

 

221.9

141.1

111.0

85.1

75.9

72.2

51.5

47.1

 

ALL CAUSES

1,030.0

1996-97

Cardiovascular diseases (heart disease and stroke)

Cancer

Chronic obstructive pulmonary diseases

Unintentional injuries

Pneumonia and influenza

Diabetes mellitus

Hereditary and degenerative diseases of the central nervous system

Diseases of the arteries, arterioles and capillaries

 

 

240.2

184.8

28.4

27.7

22.1

16.7

14.7

14.3

 

ALL CAUSES

654.4

Nota: Disease categories not identical over time.  Rates in 1996-97 are age-standardized.  Source: Susan Crompton, “100 Years of Health,” Canadian Social Trends, Statistics Canada, Catalogue 11-008, No. 59, Winter 2000, p. 13.

Public health programs, combined with the large-scale introduction of vaccines and antibiotics, have led to a major shift in the pattern of diseases.  Today, although cardiovascular disease remains the leading cause of death among Canadians, its impact on mortality has declined dramatically over the past 70 years, probably reflecting changes in lifestyles (reduced levels of smoking, lower-fat diets, more exercise) and improvements in treatment (new drugs and improved medical/surgical techniques).  In contrast, cancer has become the second cause of death in Canada, compared to fifth in 1921.

 

4.1.1   Infectious Diseases

Dr. Paul Gully, Acting Director General at the Centre for Infectious Disease Prevention and Control (Health Canada), told the Committee that although some infectious diseases have been controlled or virtually cured, many infectious diseases persist.  Indeed, he stated that: “since 1980, the death rate from infectious diseases in Canada has increased.”[82]  Infectious diseases are a significant economic burden, costing more than $6 billion annually in 1998.[83]  Dr. Gully pointed to seven infectious disease trends that threaten Canadians:

·        Many infectious diseases, such as AIDS and hepatitis C, persist;

·        There are new and emerging disease threats, including mad cow disease and E. coli, as well as the West Nile Virus infection;

·        Global travel and migration can introduce new diseases into the population;

·        Environmental changes, such as global warming, deforestation, and tainted water, may cause infections, such as Lyme disease;

·        Behavioural changes, particularly high-risk sexual practices and drug use, can spread HIV and other diseases;

·        Resistance to immunization could cause a resurgence in polio and measles, for example; and

·        Anti-microbial resistance may reduce the effectiveness of traditional curative measures.[84]

 

4.1.2   Chronic Diseases

According to the National Population Health Survey, in 1998-99, more than half of all Canadians, or 16 million, reported having a chronic condition.  The most prevalent conditions were allergies, asthma, arthritis, back problems, and high blood pressure.[85]  In a written brief to the Committee, Dr. David MacLean, Department Head, Community and Epidemiology, Dalhousie University, noted:

Chronic non-communicable diseases are the major health burden today in developed countries like Canada.  They are by far the most important cause of all mortality, premature mortality, morbidity, and years of potential life years lost in Canada.  They are the leading causes of disability, loss of productivity, and deterioration in the quality of life.[86]

Cardiovascular disease is the major cause of death in Canada, accounting for 37% of all deaths. Mortality from cardiovascular disease has been declining in Canada since 1970 among both men and women, although more slowly in women. Cancer in its many forms is the second-leading cause of death and the leading cause of potential years of life lost before age 70 (over one-third of all potential years of life lost). Cancer is primarily a disease of older Canadians, with 70% of new cancer cases and 82% of deaths due to cancer occurring among those who are at least 60 years old.  Cancer death rates have declined slowly for men since 1990, while they have remained relatively stable among women over the same period.  However, lung cancer rates for women are now four times higher than they were in 1971.

Text Box: Eighty-five per cent of Canadians over 65 have at least one modifiable risk factor for cardiovascular disease, and almost two-thirds of Canadians overall have at least one factor for cardiovascular disease. Two-thirds of Canadians lead sedentary lifestyles, and over half are above a healthy weight. 

Dr. Christina Mills, Director General, CCDPC, Health Canada (6:8)

Witnesses identified some of the factors that are affecting the incidence of chronic disease.  More precisely, poor diet, lack of exercise, smoking, stress, excessive alcohol intake, and obesity were all identified as chronic disease risk factors.  Dr. MacLean suggested that most chronic diseases - such as cancers, heart disease, diabetes, and respiratory disease - are “entirely preventable” and, moreover, that the social and biological determinants of chronic diseases “can be manipulated.”[87]  In his view, however, there is a tendency to focus on curing chronic diseases, rather than preventing them.  He said that the most common chronic disease strategy “has been to deal with the issue largely as a clinical problem with significant health care resources invested in the development of specialized services utilising sophisticated diagnostic and treatment technologies.”[88]  Dr. MacLean noted that there is a limited political will to expend resources on prevention because “the outcomes from preventative work are long term.  There are no short payoffs.  For some parts of the political process, that is not an attractive issue.”[89] 

 

4.1.3   Injury

In 1995-96, there were 217,000 hospital admissions due to injury.  By far, the highest rates of hospital admissions due to injuries were among Canadians over the age of 65.  The rate was lower among people under the age of 45.  Falls remain an important cause of injury among seniors and children under 12.  Among children, the next most important cause of injury-related admission to hospital in 1996 was poisoning.  For adolescents and adults under the age of 65, the second most important cause was motor vehicle crashes.  The vast majority of injuries are accidental (about 66%).[90]  In her brief, Dr. Christina Mills, Director General, Centre for Chronic Disease Prevention and Control (CCDPC) at Health Canada, indicated that each year, $9.5 billion in direct costs are the result of injuries, in addition to $4.7 billion in compensation costs.  Most of these injuries are preventable.[91]

 

4.1.4   Mental Illness

The National Population Health Survey of 1994/95 found that approximately 29% of Canadians had a high level of stress; 6% of Canadians felt depressed; 16% of Canadians reported that their lives were adversely affected by stress; and 9% had some cognitive impairment such as difficulties with thinking and remembering.  Work prepared for the Federal/ Provincial/ Territorial Advisory Network on Mental Health estimated that about 3% of Canadians suffer from severe and chronic mental disorders that can cause serious functional limitations and social and economic impairment such as manic depression and schizophrenia.  This translates into approximately one in every 35 Canadians over 15 years of age.[92]

Mental stresses and disorders leading to mental illness can strike at different periods of life.  Autism, behavioural problems and attention deficit disorder most commonly affect children.  Adolescence is typical for the onset of eating disorders and schizophrenia.  Adulthood is a time when depression may manifest more obviously.  Seniors years are marred by Alzheimer’s and other types of dementia although depression is also being identified more often in the elderly.

 

4.1.5   The Economic Burden of Disease

According to data provided to the Committee, the total cost of illness was estimated at $156.4 billion in 1998.  Direct costs (such as hospital care, physician services and health research) amounted to $81.8 billion, while indirect costs (such as lost productivity) accounted for $74.6 billion.  The diagnostic categories with the highest total costs were cardiovascular diseases, musculoskeletal diseases, cancer, injuries, respiratory diseases, diseases of the nervous system, and mental disorders.

The economic burden of mental health problems were estimated at approximately $14 billion in 1998.  Mental illnesses and disorders were the seventh highest among all diseases in terms of the overall cost of illness.  It is estimated that mental illness is the second-leading cause of hospital use among those aged 20 to 44, a period of life normally associated with high productivity.

 

4.2     Determinants of Poor or Good Health

Disease issues are complex.  This complexity is attributable to the fact that poor or good health is dependent on a variety of factors such as biology and genetic endowment, as well as the physical environment and socio-economic conditions in which an individual lives.  More importantly, it is the interaction among these various factors that can have a significant impact on one’s state of health.  For example, Dr. MacLean noted: “Illness generally results from the interaction between an individual’s genetic make up and broad environmental factors.”[93]  This was echoed by Dr. Mills who stated that: “many major conditions share common risk factors” and, moreover, risk factors often “cluster together” in individuals.[94]

According to many experts, the most powerful influence on health is socio-economic status. Whether we look at how people rate their own health, premature mortality, psychological well-being or the incidence of chronic disease, socio-economic status remains strongly related to health status.  Differences in health status are readily evident in a comparison of the highest and lowest income groups.  Canadians with low incomes and low levels of education (which are often related) are more likely to have poor health status, no matter which measure of health is used, and people’s health improves on virtually all measures and in all of the factors that influence health as levels of income and education increase.  Canadians with low incomes are also more likely to die earlier than other Canadians, no matter which cause of death is considered. But an active gradient in health status from low to middle and upper levels of income can also be observed in virtually all measures of both mortality and morbidity. In other words, high-income Canadians are more likely to be healthy than middle-income Canadians, who are in turn healthier than low-income Canadians. Indeed, it is estimated that if the same death rates as for the highest income earners applied to all Canadians, over one-fifth of all potential years of life lost before age 65 could be prevented.

 

4.3     The Need For Health Promotion And Disease Prevention

The common thread woven through the witnesses’ presentations was the need to invest more in prevention and promotion strategies.  They pointed out that currently, there is a tendency to focus on curing diseases, rather than on preventing them.  In their view, clinical treatment has been the most common strategy and there has been only a limited political will to expend resources on health promotion and disease prevention, because outcomes from preventive work are generally visible only over the longer term, and are therefore less attractive politically.

Text Box: We certainly do not have what could be called a preventative dose of prevention programming in Canada, and there is unfortunately a history dealing with things on a one-off basis.

Dr. Christina Mills, Director General, CCDPC, Health Canada (6:9)

Witnesses stressed that with appropriate disease prevention and health promotion strategies, many chronic and infectious diseases, and most injuries, can be prevented.  According to Dr. Mills, investing in promotion and prevention is the only way to reverse disease trends and reduce the burden of illness:

Text Box: Dr. MacLean echoed this recommendation, noting, “We have not marketed [the Canada Food Guide] at all.  We have not spent what Kellogg’s spends in a week, on that guide over the past 10 years.  These things will not diffuse by osmosis to people.  If you want to change habits, particularly in people after they develop them, there is an effort required.

Dr. David MacLean, Dalhousie University (6:24)

Our only chance to slow or reverse the rate of increase [in the economic burden of disease] is to invest in effective upstream prevention.  It is quite well recognized now that failure to prepare for an increased burden due to the aging population is a threat to the sustainability of our health care system, but it is not widely recognized that our failure to invest upstream is an equally great, and perhaps even greater, threat to sustainability.[95]

Witnesses stressed that it is necessary to encourage people to make smart choices with regard to their own health.  They suggested that, to date, strategies that attempted to prescribe “good behaviour” have not been entirely successful, and noted that part of the challenge lies in creating an environment that allows people themselves to make the right choices.

Prevention and promotion efforts have to be tailored and flexible. There is no “one size fits all” strategy.  For example, sexually transmitted disease trends change as sexual practices change and therefore will always require new prevention and promotion strategies.  In this regard it is important to ensure that the marketing of health information be current.  Witnesses pointed to the Canada Food Guide as an example of a good initiative, but one that has not been marketed effectively or updated and adapted over time.

Strategies must also recognize the link between healthy communities and healthy citizens.  For example, people may be less inclined to bike or jog if the streets are unsafe.  Successful community-based programs combine an understanding of the community, with the participation of the public, and the cooperation of community organizations. Approaches that address several risk factors and that can produce multiple benefits include support for families at risk, comprehensive school health promotion programs, and comprehensive work health and safety programs.

Text Box: We must create healthier communities in Canada because many of the barriers that prevent us from being healthy are in our communities and at the community level.

Dr. David MacLean,
Dalhousie University (6:15)

Furthermore, because disease and injury are not uniformly distributed across populations, strategies must also look at the linkages between health status and demographic and environmental factors, such as age, race, region of residence, and gender. Strategies must therefore address disease and injury trends among specific demographic groups, such as youth and Aboriginal peoples.  For example, suicides and motor vehicle accidents predominantly affect young men and Aboriginal youth.  Adults over age 65 are most affected by falls, and accidents are the leading cause of death in children.  Strategies must be tailored to the situations of each affected group, and need to be targeted to the groups that will derive the most benefit from prevention.

Many witnesses pointed to the need for intergovernmental cooperation, in order to implement prevention and promotion programs.  They noted that all three levels of government should be involved, given the complexity and multiple dimensions of health issues.  Dr. MacLean recommended that:

(…) the federal government use its time-honoured way of influencing provinces, which is the 50-cent dollars.  The federal government could start by making a policy priority of trying to increase the infrastructure for prevention because they have to work with the provinces on these issues.

…We have never had a cost-shared process for public health.[96]

One difficulty that arises with regard to the elaboration of strategies for health promotion and disease prevention is that many diseases usually have several risk factors associated with them.  Comprehensive prevention and promotion strategies must therefore address the linkages between risk factors, as well as between health status and socio-economic, demographic, and environmental factors.  Approaches that address several risk factors and which can produce multiple benefits include support for families at risk, comprehensive school health promotion programs, and comprehensive work health and safety programs.  Approaches like these can be part of a broader population health strategy.

 

4.4     Population Health Strategy

Witnesses explained that several key issues with regard to population health strategies largely revolve around the difficulties associated with how to translate research evidence into actual policy that can be implemented.  In their view, there can be little doubt that population health strategies would result in improved health outcomes, but there remain significant practical obstacles to moving beyond the expression of pious good wishes to the design of concrete programs that are sustainable over the long haul.

In the first place, the multiplicity of factors that influence health outcomes means that it is exceedingly difficult to associate cause and effect, especially because the effects are often only felt many years after exposure to the cause. The Committee was told that this time lag also means that the timeframe for judging the impact of policy in this area is a long term one. Because political horizons are often of a shorter-term nature, this can constitute a serious disincentive for the elaboration and implementation of population health strategies.

Furthermore, as noted earlier, a massive infrastructure that is already in place to deal with the treatment of illness, and this creates many entrenched interests within the system.  Witnesses explained that it is not necessarily that people who treat illness have anything against promoting health — the contrary is no doubt the norm.  Rather, it is simply that massive resources must be deployed simply to sustain the existing health care infrastructure, making it difficult to find sufficient time, energy and capital to devote to the preventive, or wellness, side of the system.

Text Box: It is important to recognize that the social determinants of health are tied and people who suffer the most from [the] diseases are people who fall into lower socio-economic categories.  It is also important to link our economic and social policies to health if we want to make a dent in these issues.

Dr. David MacLean, Dalhousie University (6:15)

Moreover, the Committee heard that because of the diversity of the factors that influence health outcomes, it is very difficult to coordinate government activity in the area of population health.  Given that the health care system itself is only responsible for a relatively small percentage of the actual determinants of health, the responsibility for population health cannot reside exclusively with the various ministries of health.  Yet the structure of most individual governments does not easily lend itself to inter-ministerial regulation of complex problems, and this difficulty is compounded several times over when the various levels of government, along with the many non-governmental players, are taken into account, as they must be.

For example, the evidence concerning the existence of gradients of health that correlate with socio-economic levels is quite conclusive.  The implication of this fact is that the promotion of population health requires a strong focus on the reduction of poverty.  But there are clearly a great number of government policies that have an impact on the levels of poverty in the country and it would be impossible to ask a ministry of health to take charge of all the policy tools that are involved, if for no other reason than this would be rightly seen as a form of ‘health imperialism’ by other ministries. It is also somewhat perverse, as one witness pointed out, to argue for the reduction of poverty exclusively on the health terrain.  Any such initiative would have to come about as a result of the overall social policy orientation of government, something that is considerably broader than health policy alone.

Overall, the evidence suggests that population health strategies in general should be carefully thought through so that they take into account the realities facing specific communities.  This implies that rigidly-designed programs applied in a uniform and highly centralized fashion are unlikely to succeed.  Some combination of coordination and decentralized implementation therefore would seem to be required.

Although there are many difficulties associated with the development of an effective population health approach, the witnesses contended that it is important for the federal government to continue to try to set an example by exploring innovative ways to turn good theory into sound practice that will contribute to improving health outcomes in Canada.

 

4.5     Research

Many witnesses told the Committee that greater research is needed, particularly in certain areas. Often, money is spent without sufficient epidemiological research to guide where it is invested.  For example, billions of dollars have been spent on breast cancer screening programs, but there has been minimal research on the physiology and biology of the disease, or on the intersection of risk factors that contribute to its development.

Dr. MacLean also told the Committee that more research on prevention strategies is needed.  He pointed to the budgetary increases for the Canadian Institutes of Health Research (CIHR), but wondered whether or not those new resources would be directed at health promotion and disease prevention research.  Dr. Mills noted that CIHR’s expanded mandate offers an “opportunity to support additional research required to determine what is most effective to create lasting behaviour change.”[97]

In terms of chronic disease research, witnesses told the Committee that the problem, essentially, is not a lack of data or research, but a lack of knowledge on how to use that information in the implementation of preventive strategies.  In this respect, research is needed to determine how best to share health information with people and, in particular, how best to target that information to those in lower socio-economic groups or those with poor literacy skills.

In terms of infectious disease research, Dr. Gully noted that although resources are being directed to research initiatives, such as the CIHR and the Health Canada laboratory in Winnipeg, “it is always difficult to make a bid for contingency funds for new [infectious disease] threats.”[98]  He pointed to the difficulty of balancing resources for immediate threats with those for other, less immediate, issues. 

With respect to mental illness, witnesses stressed the need to invest more in applied research.  In their view, research into mental illness and mental health is vastly under-funded in relation to the economic burden of mental disease and disorder.  It was suggested that the federal government should take the lead in promoting a comprehensive research agenda on the mental health issue.

Witnesses indicated that we need to spend more on the infrastructure for disseminating the evidence generated by health research.  According to Dr. Gully, federal funding in this area would allow data to be collected from, and shared among, all of the provinces and territories.  He pointed to the Internet as a tool for such an undertaking.  This idea was echoed by Dr. MacLean, who told the Committee about the Health Promotion web site developed in Nova Scotia, which provides health-related information to users.

 

4.6     Committee Commentary

Although the witnesses addressed a wide range of issues, the primary emphasis was on the need to increase disease prevention and health promotion programs.  Witnesses noted that the federal government could play an important role in preventing disease and promoting healthy lifestyles.  Moreover, they suggested that appropriate, comprehensive, and targeted disease prevention and health promotion programs would have a significant effect on both the health of Canadians and Canada’s health care system.  Such programs would improve quality of life, increase productivity, decrease unintentional disability and premature death, and reduce the economic burden of disease.

Canada is one of the healthiest countries in the world, with high life expectancy, low infant mortality rates, and a good quality of life.  These successes, however, should not conceal the challenges that persist.  Chronic diseases - such as cancer, heart disease, and respiratory problems - are the leading cause of death in Canada.  Diseases that had, at one time, virtually disappeared, such as tuberculosis, are re-emerging, and increased international mobility has accelerated the spread of other diseases.  Moreover, in 1997, accidents killed more than 13,000 Canadians.  Finally, the prevalence of disease varies among different demographic groups and populations, striking, in particular, Aboriginal peoples, and the poor.

A diversity of factors influences health outcomes.  Population health strategies are broadly based policies that take all these determinants of health into account with the aim of improving the health of an entire population.  The main objective of population health is to ward off potential health problems before they require treatment within the health care system.  These strategies can greatly contain the demand for health services and reduce the economic burden of disease.

The Committee concurs with witnesses that the federal government has a definite role in health promotion and disease prevention.  Similarly, the federal government has been recognized as a leader worldwide in developing the concept of population health.  In our view, the federal government should, once again, show leadership in implementing a population health strategy for all Canadians.  This is a feasible task, given its current role in many areas that affect health, such as the environment, economic policy, workplace safety, etc.


CHAPTER FIVE:

The Health of Aboriginal Canadians

There are notable disparities between the health of Canada’s Aboriginal population and the health of the general Canadian population.  The Aboriginal population experiences poorer health, lower life expectancies, higher infant mortality rates and higher rates of some chronic illness.  There are also significant socio-economic disparities between Aboriginal people and the general population – unemployment rates are higher and education and average income levels are lower.

This chapter provides a brief demographic, socio-economic and health profile of Canada’s Aboriginal population.  It also highlights federal programs directed to Aboriginal health and discusses the Aboriginal health policy of the federal government.

 

5.1     Demographic Profile of Canada’s Aboriginal Population[99]

Aboriginal people constitute approximately 3% of Canada’s total population.  The Constitution Act, 1982 recognizes three groups of Aboriginal peoples: Indians, Inuit, and Métis.  The Indian population includes both status and non-status Indians.  The Indian Act sets out the legal definitions that apply to status Indians (First Nations) in Canada, that is, Indians who are registered under the Indian Act.  Non-Status Indians are those who are not registered under the Act.  The Inuit population of Canada lives primarily in communities in the Northwest Territories, Nunavut, Nunavik and Labrador.  About 6% of Inuit live in southern Canada.  Inuit are not specifically covered by the Indian Act but receive certain benefits from the federal government.  Métis people are of mixed Indian and European ancestry.  The Métis are not covered by the Indian Act and do not receive Métis-specific benefits from the federal government.

As Graph 5.1 shows, Canada’s total Aboriginal population was estimated at 1,398,400 in 2000 and comprised: 28.5% of Status Indians living on reserve, 30.6% of Non-status Indians, 20.8% of Status Indians off reserve, 15.6% of Métis, and 4.5% of Inuit.[100]

Canada’s Aboriginal population is diverse. There are over 600 First Nations communities, comprising over 50 nations or cultural groups and more than 50 languages.  Approximately 63% of First Nations communities have fewer than 500 residents — 5% have more than 2,000.  Although the Inuit communities share the same language, Inuktitut, they have different dialects from one region to another.  Most Inuit communities have fewer than 1,000 persons.  The Métis have developed their own distinct language, known as Michif, from a mixture of French, English, Cree and Ojibway.  The Métis population is mainly concentrated in Manitoba, Saskatchewan and Alberta; about 10% of them live in Métis settlement lands.

Canada’s Aboriginal population is becoming increasingly urbanized.  The urban Aboriginal population experienced rapid growth between 1981 and 1991, increasing by 55 percent (compared to an 11 percent increase in urban non-Aboriginal residents).  Although its future rate of growth is expected to be slower, the urban Aboriginal population is still anticipated to grow by 43 percent in the next 25 years, from 320,000 in 1991 to 457,000 in 2016.  In 1996, about one-fifth of the Aboriginal population lived in seven of the country’s 25 largest census metropolitan areas – Winnipeg, Edmonton, Vancouver, Saskatoon, Toronto, Calgary and Regina. 

Overall, the Aboriginal population is growing at twice the rate of the Canadian population and is younger on average than Canada’s general population.  In 1996, the average age of the Aboriginal population was 25.5 years, 10 years younger than the average age of the general population.  Children under age 15 comprised 34% of all Aboriginal people, compared to 21% of Canada’s total population.  Young people in the 15-24 age range constituted a greater portion of the Aboriginal population (18%) compared to the general population at 14%.  Seniors currently make up a relatively small proportion of the Aboriginal population in Canada.  In 1996, just 4% of people who reported they were North American Indian, Métis, or Inuit were aged 65 and over, compared with 11% of the general population.

 

5.2     Socio-economic Profile and Physical Environment[101]

There are significant socio-economic disparities between Aboriginal peoples and the general Canadian population.  Aboriginal peoples are less likely to be in the labour force, and unemployment rates are higher than those of the general population.  In 1997-98, the unemployment rate on reserves was almost triple the national rate, and reliance on social assistance was four times the Canadian rate.  The Royal Commission on Aboriginal Peoples (1996) reported that the unemployment rate for the urban Aboriginal population was two and a half times greater than that of their non-Aboriginal counterparts.  In 1995, the average employment income of the Aboriginal population was $17,382 compared to the national average of  $26,474.  Average annual income from all sources for Aboriginal people in urban areas trailed 33 percent behind that of non-Aboriginal residents.

According to the recent report, Toward a Healthy Future: Second Report on the Health of Canadians, in 1994 at least 44 percent of the Aboriginal population and 60 percent of Aboriginal children under six years of age lived below Statistics Canada’s low income cut off measure.[102]  The incidence of poverty among the urban Aboriginal population is high.  The 1991 census found that more than 60 percent of Aboriginal households in Winnipeg, Regina and Saskatoon were below the low-income cut-off line.  For single-parent households headed by women, the percentage was even higher. 

Overall, levels of educational attainment among the Aboriginal population are lower than those of the Canadian population as a whole.  In 1996, 54 percent of the Aboriginal population aged 15 years and over did not have a high school diploma. The comparable figure for the non-Aboriginal population was 16 percent.  Differences between 1981 and 1996 data show improvement in educational attainment – the proportion of the Aboriginal population with less than a high school education dropped from 59 percent to 45 percent, a greater proportion of the Aboriginal population aged 20 to 29 had obtained a college degree or diploma (23 percent in 1996, 19 percent in 1981) and the proportion of Aboriginal university graduates rose by 1 percent (from 3 percent to 4 percent), but are still below comparable measures for the general Canadian population.

A Second Diagnostic on the Health of First Nations and Inuit People in Canada noted that one’s “physical environment is an important factor in the exposure to risks such as infectious organisms, chemical and biological contaminants, stress levels, and injury.”[103] The report made the following points about the physical environment of many Aboriginal people:

·        Aboriginal people appear to be the largest population sub-group that is the most at risk of becoming homeless in Canada;

·        Crowded housing conditions are much more prevalent among the Aboriginal population than among the general Canadian population;

·        Significant numbers of Aboriginal people (43%) live in inadequate housing;

·        Mold growth is a recently identified issue in aboriginal housing but the full extent and impact on health is not yet known;

·        First Nations and Inuit people are more at risk of exposure to environmental contaminants because of their traditional diet of fish and marine mammals;

·        Access to clean, safe drinking water and adequate sewage disposal is an issue for a number of Aboriginal communities.[104]

 

5.3     Health Profile of the Aboriginal Population[105]

There are significant differences in health status between the Aboriginal population and the Canadian population.  Toward a Healthy Future: Second Report on the Health of Canadians noted that the Aboriginal population experiences poorer health than the general Canadian population, as evidenced by lower life expectancies, higher infant mortality rates and higher rates of some chronic illness.  Many other reports made similar observations:

·        Aboriginal people suffer from chronic diseases (hypertension, arthritis, diabetes and heart disease) more so than the general population. Diabetes is one of the leading causes of illness and disability among First Nations.  Current evidence indicates that diabetes is more than three times as prevalent in Aboriginal communities as in the general population. The following table of chronic disease rates taken from A Second Diagnostic on the Health of First Nations and Inuit People in Canada, illustrates the depth of the chronic disease problem among the Aboriginal population.

  Text Box: (…) the First Nations life expectancy falls somewhere around the 1970 level of all Canadians. (…) To put this in a broader perspective, the life expectancy of First Nations is lower than in all of the 25 countries with the longest life expectancy. Looking at the age-standardized mortality rates, for First Nations men the rate is 1.4 times higher; for First Nations women it is 1.9 times higher.  The age-standardized mortality rate for women actually falls somewhere around 1958 levels, when you look at the level for all Canadians.  Infant mortality is still two times higher for First Nations relative to all others.  We are looking at First Nations women with an infant mortality rate of 11.5, as against the Canadian average of 6. Again, the rates are similar to years in the mid-1970s.

Dr. Judith Bartlett (16:58)

 

TABLE 5.1

CHRONIC DISEASES

 

 

 

CHRONIC CONDITION

 

 

 

GENDER

AGE ADJUSTED PREVALENCE (%)

 

FN&I

TO CANADIAN RATIO

FIRST NATIONS AND INUIT

(FN&I)

GENERAL CANADIAN POPULATION

Heart Problems

Male

13

4

3.3

Female

10

4

2.5

Hypertension

Male

22

8

2.8

Female

25

10

2.5

Diabetes

Male

11

3

3.7

Female

16

3

5.3

Arthritis/Rheumatism

Male

18

10

1.8

Female

27

18

1.5

Source: Table taken from A Second Diagnostic on the Health of First Nations and Inuit People in Canada, November 1999, p. 17.

·        First Nations men and women on reserves have approximately three times the rate of heart problems and hypertension compared to the general Canadian population. (First Nations and Inuit Regional Health Survey, National Report 1999).

·        Between 1991 and 1996, age-standardized tuberculosis rates were almost seven times higher among First Nations persons living on reserves than the rate for the general Canadian population. The current incidence of TB among First Nations living on reserves is 18 times higher than the rate for the Canadian-born non-Aboriginal population (A Second Diagnostic on the Health of First Nations and Inuit People in Canada)

·        Despite major improvements since the 1970s, infant mortality rates for First Nations communities continue to be double the rate for Canada as a whole (Toward a Healthy Future: Second Report on the Health of Canadians).

·        The suicide rate among the Aboriginal population for all age groups is about three times higher than the rate for the population of Canada as a whole
(A Second Diagnostic on the Health of First Nations and Inuit People in Canada).  Among Aboriginal youth, the suicide rate is five to six times higher than the suicide rate of the general Canadian youth population.  Data taken from Evaluation of Models of Health Care Delivery in Inuit Regions indicate that the suicide rate for Canada’s Inuit regions is approximately 6 times higher than the rate for the general Canadian population.

·        Alcohol, substance and solvent abuse is common in a number of First Nations and Inuit communities.

·        Fetal Alcohol Syndrome/Fetal Alcohol Effects is much higher in some Aboriginal Communities than in other parts of Canada (A Second Diagnostic on the Health of First Nations and Inuit People in Canada).

·        The rate of deaths due to injuries and poisonings is 6.5 times higher for First Nations and Inuit than for the total Canadian population (A Second Diagnostic on the Health of First Nations and Inuit People in Canada).

·        A 1999 study reported that the annual number of Aboriginal AIDS cases has increased significantly.  In 1996-97, cases had risen to 10% of the total AIDS cases (up from 2% in 1989).[106]

·        Smoking is more prevalent in the Aboriginal population.  The First Nations and Inuit Regional Health Survey indicates that 62% of adult First Nations peoples living on reserve and in Labrador Inuit communities are smokers and over 70% of all respondents to the survey aged 20-29 were smokers.

·        Obesity is a major health problem among the Aboriginal population.

Approximately 75% of Aboriginal women are victims of family violence and up to 40% of children in some Northern communities have been physically abused by a family member (A Second Diagnostic on the Health of First Nations and Inuit Peopole in Canada).

·        Overall, life expectancy rates for Aboriginal peoples are lower by some
6 years than comparable statistics for the general population.

·        Many Aboriginal people have reduced access to health care services because of the remote geographical location and small size of several Aboriginal communities.  Seventy-seven percent of communities have fewer than 1,000 people and many (44 percent) are found in isolated, semi-isolated or remote-isolated areas of Canada.[107]

 

5.4     Federal Programs Directed to Aboriginal Health

Health care is delivered to Canada’s Aboriginal people through a complex array of federal, provincial and Aboriginal-run programs and services.  In addition, the framework for the delivery of a number of federal programs is changing as Aboriginal communities, governments and organizations take control over the delivery of health-related programs.

Who delivers what to whom depends on a number of factors such as status under the Indian Act, place of residence (on or off-reserve), the location of one’s community (non-isolated or remote), and whether Health Canada has signed an agreement to transfer the delivery of certain health services to an Aboriginal community or organization.

In his testimony, Ian Potter, Assistant Deputy Minister, First Nations and Inuit Health Branch at Health Canada, told the Committee that Status Indians (First Nations) under the Indian Act are a federal responsibility.  The provision of hospital and physician services, however, is a provincial or territorial responsibility.  First Nations who reside on reserves are entitled to the general health services provided by the provinces and territories such as hospitals, physician services, and other insured services covered by provincial and territorial health plans.  Health Canada, however, provides direct primary care and emergency services on reserves in remote and isolated areas where no provincial services are available.  More precisely, the department operates 4 small hospitals, 77 nursing stations and 217 health centres.

Health Canada also provides community-based health promotion and prevention services or funding for such services for First Nations people living on reserves.  Regardless of residence (on or off–reserve), First Nations people receive non-insured health benefits (NIHB) funded by the federal government.  These benefits include drugs, medical supplies and equipment, dental care, vision care, medical transportation, provincial health care premiums and crisis mental health counselling.[108]

Provincial and territorial governments are responsible for delivering health services to Inuit, but delivery of health services to Canada’s Inuit population varies with jurisdiction of residence.  In 1988, the federal government transferred responsibility for health administration to the Government of the Northwest Territories.  With the creation of Nunavut, the Nunavut government assumed this responsibility for the Nunavut region.  The federal government provides funds to the territorial governments to deliver health programs for First Nations and Inuit including non-insured health benefits.[109]

As a result of the James Bay and Northern Quebec Agreement, the federal government transferred responsibility for Inuit health services in northern Quebec to the government of Quebec then to Nunavik.  The Nunavik Regional Department of Health and Social Services administers federal and provincial programs in that region.[110]

In Labrador, the province provides health services to all residents and the federal government provides funding to the Labrador Inuit Health Commission through a transfer agreement and contribution agreements for specific projects and for a range of federal programs including non-insured health benefits.[111]

Métis and non-status Indians are not eligible for federal health programs. They receive medical services from provincial and territorial governments on the same basis as other Canadians.  Métis and non-status Indians are not included under the Indian Act and are not eligible for non-insured health benefits funded by the federal government.

The federal government responsibilities with respect to First Nations and Inuit health services are carried out by Health Canada’s First Nations and Inuit Health Branch (FNIHB) (formerly the Medical Services Branch).  FNIHB’s overall responsibilities include: 

            ·        the provision of community-based health promotion and prevention programs to First Nations living on reserves and to Inuit communities (including public health, health education and promotion, as well as strategies to address specific health problems such as alcohol and drug abuse);

·        the provision of non-insured health benefits (NIHB) to First Nations and Inuit people regardless of residence in Canada;

·        the provision of primary care and emergency services in nearly 200 isolated and semi-isolated areas where no provincial services are readily available;

·        public health services in over 400 communities;

·        funding addiction services through treatment centres and addiction treatment workers.

Overall, the expenditures of the First Nations and Inuit Health Program for 2000-01 were estimated at $1.3 billion.  About 53 percent or $677.6 million of this amount was devoted to expenditures on community health services, 45 percent or $578 million to non-insured health benefits, and 2 percent or $23.5 million to hospitals. 

In his testimony, Mr. Potter outlined several challenges faced by the First Nations and Inuit health programs.  These include: an increasing client base; a shortage of doctors and nurses; providing service in remote and isolated communities; maintaining and attracting physicians and nurses to work in isolated communities; difficult access to some specialized services; significant cost increases associated with drug benefits, medical technology and transportation; and increases in the rate of chronic diseases that require long-term care and drug therapy.[112]

Working to change the underlying social and economic conditions such as poverty, inadequate housing and low levels of education that are also important determinants of health and achieving better coordination with the provinces were also identified as important challenges.[113]

In addition to Health Canada, eleven other federal government departments offer programs for Aboriginal people.  Total expenditures for these programs for 2001-02 are estimated at $7.3 billion.  The vast majority of this money (70 percent) falls under the budget of Indian and Northern Affairs Canada (INAC) followed by Health Canada at 19 percent ($1.3 billion), Canada Mortgage and Housing Corporation (CMHC) at 4 percent and Human Resources Development Canada (HRDC) at 3 percent.  A number of other departments make up the remaining 3 percent. 

Indian and Northern Affairs Canada’s mandate includes social assistance programs, funding for elementary, secondary and post-secondary education, on-reserve housing, child and family services; and services on reserves such as homemaker services.  INAC also funds infrastructure projects in Aboriginal communities.  These include water and sewer services, environmental remediation, roads and bridges, fire protection, electrification, education facilities and other community facilities.

Other federal departments are also involved in the funding of a number of Aboriginal business development and workforce participation initiatives.

 

5.5     Aboriginal Health Policy at the Federal Level

The historic relationship between the federal government and Canada’s Aboriginal peoples sets the context for federal policy and initiatives in relation to Aboriginal health.  Table 5.2 outlines a number of events in this relationship.  In its brief to the Committee, the National Aboriginal Health Organization (NAHO) explained:

The federal government’s policy relationship with Aboriginal groups has seen significant change in the last decade. As little as fifteen years ago, federal Aboriginal resources for health and social programs were directed almost exclusively to First Nations and Inuit communities; non-reserve groups received limited programs from the federal government (examples would be off-reserve housing programs and the Canadian Aboriginal Economic Development Strategy) and indeed these groups were virtually invisible to the Canadian public. Today, the federal government’s policy focus remains directed to First Nations and Inuit, however, several Aboriginal-wide initiatives have been developed which also involve the non-status, off-reserve and Métis populations.[114]

Table 5.2

Significant Health Policy Events:  
Aboriginal Peoples – Federal Government Relationship
 

YEAR

EVENT

DESCRIPTION

1867

Constitution Act, 1867

Gave the federal government jurisdiction over “Indians and Land reserved for the Indians”

1876

Indian Act

Enactment of the federal Indian Act

1939

Supreme Court of Canada decision

Recognized that the term “Indian” in the Constitution includes Inuit

1945

Shift in health services

Responsibility for Indian health services was transferred from Indian Affairs to the Department of National Health and Welfare

1962

Medical Services Branch (now the First Nations and Inuit Health Branch)

The Medical Services Branch was created within the Department of National Health and Welfare to amalgamate Indian Health and Northern Health

1979

Indian Health Policy

Goal: “to achieve an increasing level of health in Indian communities, generated and maintained by the Indian communities themselves”. Improvements to the health status of the Indian population should be built on three pillars:

1.      community development;

2.      the traditional relationship between Indian people and the federal government; and

3.      the interrelated Canadian health system, with its federal, provincial, municipal, Indian and private sectors.

1980

Berger Report

Recommended methods of consultation that would ensure substantive participation by First Nations and Inuit people in the design, management and control of health care services in their communities.

1982

Constitution Act, 1982

Recognition of First Nations, Inuit and Métis and enshrinement of existing Aboriginal and treaty rights in the Canadian Constitution

1988

Transfer Policy Approval

Federal Cabinet approved the health transfer policy framework for transferring resources for Indian health programs south of the 60th parallel to Indian control.

1990s

Supreme Court of Canada

Various Supreme Court of Canada decisions with respect to the government’s fiduciary responsibility to Aboriginal people

1995

Self-Government Policy

The Government of Canada recognizes the inherent right of self-government as an existing right within section 35 of the Constitution Act, 1982. Health is one of the subject matters that could be covered in self-government negotiations.

1996

Report of the Royal Commission on Aboriginal Peoples (RCAP)

Report made a number of recommendations in relation to Aboriginal health. Aboriginal health and healing systems should embody the following characteristics:

1.      equity in access to health and healing services and in health status outcomes;

2.      holism in approaches to problems and their treatment and prevention;

3.      Aboriginal authority over health systems and, where feasible, community control over services; and

4.      diversity in the design of systems and services to accommodate differences in culture and community realities.

1998

Gathering Strength: Canada’s Aboriginal Action Plan -- Federal government response to the RCAP report

Gathering Strength focuses on: Renewing the Partnerships with Aboriginal people; Strengthening Aboriginal Governance; Developing a New Fiscal Relationship; Supporting Strong Communities, People and Economies

The Committee was told that federal Aboriginal health policy has followed a continuum that reflects developments in both the Canadian health care system at large and the evolving relationship between the federal government and Aboriginal people.  During the first half of the 20th century, federal Aboriginal health initiatives focused on medical care, rather than on providing comprehensive services to the First Nations and Inuit populations.  This included the operation of nursing stations, health centres and hospitals.  With the introduction of universal Medicare, the provision of public health and preventative measures rather than the delivery of direct health care became the main emphasis of federal Aboriginal health activities, although Health Canada has continued to provide primary health services in remote and isolated areas.  For the most part, however, federal Aboriginal health initiatives are limited to First Nations and Inuit.  Métis and non-status Indians benefit from only a limited number of federal programs.[115]

The federal Indian Health Policy 1979 established the general policy framework for the provision and payment of health services by the federal government to First Nations and Inuit.  The stated goal of the Policy is “to achieve an increasing level of health in Indian communities, generated and maintained by the Indian communities themselves”.  The Policy provided that improvements to the health status of the Indian population should be built on three pillars:

1.      community development (socio-economic and cultural/spiritual) in order to remove the conditions which limit the attainment of well-being;

2.      the traditional trust relationship between Indian people and the federal government; and

3.      the Canadian health care system, with its federal, provincial, municipal, Indian and private sectors.

Another important feature of the Policy was the recognition that First Nations and Inuit communities could take over the administration of their own community health programs.  To achieve this objective, in the mid-1980s the federal government began to emphasize the transfer of control over health services to First Nations and Inuit communities and organizations.

Table 5.3 shows the status of transferred communities as of March 31, 2000 and the projected transfers to 2005. The total number of eligible First Nations/Inuit communities is 599.  As of fiscal year end 1999/2000, a total of 276 (46 percent) of these communities had signed a Health Services Transfer Agreement.

Table 5.3:

Health Services Transfers

TRANSFERS BY REGIONS/COMMUNITIES

Region

Total Eligible Communities

Transfers as of

March 31, 2000

Projected Transfers to
March 31, 2005

Number

Number

% Total

Number

% Total

Atlantic

40

20

50

36

90

Quebec

28

23

82

28

100

Ontario

124

38

31

57

46

Manitoba

62

33

53

52

84

Saskatchewan

83

60

72

68

82

Alberta

58

4

7

10

17

Pacific

204

98

49

109

53

TOTAL

599

276

46

360

60

Source:  Health Canada, First Nations and Inuit Control, Annual Report, 1999-2000 (available at http://www.hc-sc.gc.ca/msb/pptsp/annual_e.htm#T3).

 

5.6     Barriers to Aboriginal Health and Wellness

During the hearings, witnesses outlined a number of jurisdictional and structural issues in relation to Aboriginal health services that have the effect of impeding or denying access to appropriate health care services.

Text Box: All of the provinces are at different levels with their involvement in providing health programming to Aboriginal people.

Dr. Judith Bartlett, National Aboriginal Health Organization (16:59)

 

Jurisdictional barriers to the provision of health services to Aboriginal people exist on two levels. The first barrier arises from the division of powers between the federal and provincial governments.  Provincial governments provide equal access to health care services under the Canada Health Act for all residents including First Nations living on reserves and Inuit but take the position that the federal government is responsible for certain health services to Aboriginal persons who are Indians under the Indian Act (Status Indians).  As a result, witnesses indicated that health services not covered by the Canada Health Act but otherwise provided by the provinces may or may not be provided to First Nations and Inuit communities.[116]

Text Box: The division of powers and fragmentation among the various services, service providers and authorities create confusion regarding the services to which Aboriginal people are entitled. It is not just the recipients that suffer, but also the people providing the services and community managers.

Michelle Audette, Native Women Association of Quebec (16:38)

Other consequences of having two jurisdictions involved in delivering health services include program fragmentation, problems with coordinating programs and reporting mechanisms, inconsistencies, gaps, possible overlaps in programs, lack of integration, the inability to rationalize services, and impediments to developing a holistic approach to health and wellness. 

The second jurisdictional barrier stems from the divisions among Aboriginal peoples that arise as a result of the Indian Act.  Because Métis and non-status Indians are excluded from the legislation, they are not eligible for most federal programs. The NAHO and the Métis National Council stressed before the Committee that lack of recognition leaves the Métis and non-status populations in a jurisdictional void.  For example, Dr. Judith Bartlett noted:

There are no primary care services specifically targeted to Métis and non-status Indian populations. (…) The Métis and non-status are in a jurisdictional void. They, in fact, are excluded from legislation, and this impacts on their eligibility for programs.[117]

Similarly, Gerald Morin, President of the Métis National Council, told the Committee:

Federal and provincial jurisdictional disputes, cultural barriers and geographic isolation … impede our access to the health care system. Métis communities are facing many of the same health challenges as other Aboriginal communities but the difference is that Métis health issues receive limited and scant attention from the federal government.  The fundamental issue at stake for the Métis is the unwillingness of Health Canada to deal equitably and fairly with the Métis people as one of the indigenous peoples in Canada.[118]

Witnesses told the Committee about the restrictive nature of the federal health transfer policy that transfers control of federal health programs south of 60° to First Nations and Inuit communities and organizations.  It was observed that the NIHB, a program comprising nearly half of Health Canada’s funding to First Nations and Inuit, is not eligible for inclusion in the transfer process.[119]  Furthermore, the NAHO noted that Health Canada’s policy with respect to the transfer of health services to Aboriginal organizations does not include a framework that would “facilitate the integration of federal and provincial services.”[120]  Again, this creates barriers to program rationalization and the development of a comprehensive approach to Aboriginal health.

Witnessed also pointed out that structural barriers arising from geography, isolation and small community size in rural and remote areas have an impact on access to health services and the comprehensiveness of available services.  High turnover rates for health workers, changes in visiting physicians, language, and the lack of integration of traditional and western health systems also constitute barriers.  Witnesses stressed that structural barriers are not just confined to rural and remote areas – in urban settings barriers exist as well but may be secondary to issues relating to the cultural appropriateness of care and lack of access due to poverty.[121]

Ron Wakegijig, a healer from the Wikwemikong Health Centre, pointed out that because of the differences between the concerns, issues and requirements of remote, isolated or semi-isolated Aboriginal communities and more urbanized southern Aboriginal communities, national policies developed for all Aboriginal people may not adequately address specific regional concerns.[122]

A number of witnesses emphasized to the Committee that Aboriginal peoples are not a homogeneous group.  Inuit witnesses called for this distinctiveness to be recognized in the delivery of health programs and research.  Pauktuutit Inuit Women’s Association of Canada stressed the importance of meaningful involvement of Inuit in the development of programs and policies that affect Inuit health.  Pauktuutit noted that often the terms “Aboriginal health” and “First Nations health” have become one and the same; with the result that programming is not based on the input and needs of Inuit.

The term “Aboriginal health” is often misunderstood to be synonymous with First Nations Health. That misinterpretation is a reflection of the lack of clear understanding of the Indigenous people of Canada and their three distinct cultures.  For Inuit, the impact is most significant in the area of health programming.  Aboriginal Health Programming continues to be First Nations focused, too often developed with minimal, if any meaningful Inuit consultation and rarely reflective of the specific linguistic and cultural needs of Inuit.  Further, it does not reflect the realities of program delivery in isolated/remote communities nor acknowledge the differences in infrastructure that exist between First Nations and Inuit communities.  Programs designed for First Nations are often imposed upon Inuit when, in actuality, alternative, Inuit-specific, community based programming would better meet the needs of Inuit community members. [123]

Witnesses involved in the hearings on Aboriginal health stressed that the traditional concepts of health and wellness in all Aboriginal communities are holistic, multifaceted and community focused:

The First Nations concept of wellness encompasses the four realms of human existence. Some First Nations refer to this concept as “the medicine wheel.” It is believed that well-being and optimum health can only be achieved by addressing not only the physical aspects of health, but also the emotional, mental and spiritual needs of an individual. Those fundamentals make the First Nation view far more holistic than the biomedical model.

The medicine wheel illustrates that First Nations people believe that a person is not only a body. If a person is to be healthy or achieve wellness then each of the four aspects of their life must be in balance. Appropriate attention must be given to each of the four aspects of a person. Not only must one be balanced, one must live in a balanced, harmonic community. Harmony must be addressed at all levels of existence and aspects of life. The prevention of illness and the promotion of good health and healthy lifestyles must be addressed through healthy communities and governments.[124]

Aboriginal people define health and illness in terms of balance, harmony, holism and spirituality rather than in terms of the Western concepts of physical dysfunction and disease within the individual.  Aboriginal wellness emphasizes that solutions to health will not be effective until all factors having an impact on a problem are considered. Witnesses suggested that federal Aboriginal health policy must develop a greater focus on prevention, population health and a holistic approach to health that includes health promotion and community-based program planning.  For example, the Assembly of First Nations observed:

Poverty, ill health, educational failure, family violence and other problems reinforce one another. To break this circle, all determinants should be addressed together, in a coordinated strategy, not a piecemeal approach.[125]

The Committee was told that much of the current research has been focused on First Nations.  Dr. Judith Bartlett pointed to the paucity of Métis and Inuit-specific research data.  The President of the Métis National Council confirmed that there is a lack of research, data and information with respect to the health conditions and the demographics of Métis people.  The Inuit Tapirisat of Canada cited the lack of Inuit-specific health information as a key challenge.  Pauktuutit Inuit Women’s Association of Canada echoed this concern and noted that problems arise when information from larger data sets is used in the context of another Aboriginal peoples.

Identifying new and emerging health issues for Inuit is often complicated by a lack of “hard” data and by a reluctance to use innovative anecdotal indicators in research methodology.  Inuit-specific health data is spotty at best and often extrapolated from larger pools of Aboriginal data collected mainly in southern Canada.  For Inuit to adequately plan and prioritize health issues, for them to identify changing trends in disease, data must be collected by Inuit about Inuit and for Inuit. One prime example is HIV/AIDS surveillance data.  Inuit statistics are extrapolations of data collected in two provinces, Alberta and British Columbia, primarily large urban centres.  This has resulted in an overwhelming focus on and disproportionate distribution of funding on prevention programs for “Aboriginal” intravenous drug users, which have little, if any, relevance to Artic Inuit.[126]

Witnesses also stressed the importance of research on Aboriginal health issues that encompasses Aboriginal-directed and controlled research.  Dr. Jeff Reading of the Institute of Aboriginal Health (CIHR) told the Committee:

Undertaking research can be a significant determinant of health in its own right. It is a determinant of health because people are able to take control over factors affecting their lives. The context of native communities has been one where people outside the community have managed control for a great period of time. Now people have the opportunity to seize control and to start interpreting data about themselves.

When people participate in the creation and understanding of knowledge about themselves, they take greater ownership of their health problems and, in so doing, become active in terms of solving those problems.  Research is the first step in terms of the drive toward self-determination and improved health status.[127]

 

5.7     Committee Commentary

The Committee acknowledges that many reports have been written and many suggestions made for changes to benefit Aboriginal people.  Repeatedly, this particular population of 1.3 million Canadians has been designated by international, national and regional bodies as the most needy in the country.  In spite of the breadth of effort being undertaken, the state of health of Aboriginal Canadians and the socio-economic conditions in which they live remain deplorable.

The Committee heard about the various federal health strategies coordinated by Health Canada and the multiple programs managed by Indian and Northern Affairs Canada.  Still, an enormous amount remains to be done if we are to reduce disparities in health status and socio-economic disparities between Aboriginal people and the general population.  The Committee feels that, given the wide range of programs that the federal government currently manages and given its specific constitutional responsibilities, it must develop population health strategies aimed specifically at Aboriginal Canadians.  These strategies must include dealing with economic conditions, environmental issues such as clean and safe drinking water, high-quality and culturally sensitive health care, healthy lifestyle choices, etc. It is also important, as suggested by Ron Wakegijig and others, to consider ways to integrate traditional healing approaches to Aboriginal health with mainstream health care.

Jurisdictional barriers should not be used as an excuse to progress slowly in this field.  The Committee believes that these barriers can be overcome rapidly, and that all levels of government – federal, provincial, territorial, municipal, band and settlement – must develop a comprehensive plan that could meet the needs of all Aboriginal people in Canada.  The federal Minister of Health should play a leadership role in coordinating such a plan.

The Aboriginal population is young and growing.  It is imperative to develop programs that are sustainable in the long-term period.  The Aboriginal community is also diverse.  Programs must be designed in a way that accommodate differences in culture and community realities.

The Committee believes that undertaking research on the health of Aboriginal people can provide useful information on how to improve service provision and health outcomes.  The Committee welcomes the new Institute on Aboriginal Health at the CIHR and believes it is essential that it be provided with a sufficient level of funding.


CHAPTER SIX:

Human Resources

Canada’s health care system is a labour-intensive industry.  About one in ten employed Canadians work in the health care sector.  Many more help to care for their friends and family members.  Therefore, our system depends on having a steady supply of appropriately distributed, well-trained and experienced health care providers and committed volunteer caregivers. (The issues concerning volunteer or informal caregivers are presented in more detail in Chapter Nine).

A complex mix of health care providers – comprising more than 30 provincially regulated professional groups – delivers care to Canadians.  Table 6.1 shows the total number of licensed health care providers per 100,000 Canadians and the percentage change in these numbers over a 10-year period.

 

TABLE 6.1

REGULATED HEALTH CARE PROVIDERS IN CANADA
(Number Per 100,000 Canadians and Percentage Change)

 

1989

1998

Change

Registered Nurses

Licensed Practical Nurses

Physicians

Pharmacists

Dentists

Physiotherapists

Psychologists

Dental Hygienists

Chiropractors

Optometrists

809

301

187

67

52

37

32

29

12

11

750

250

185

76

54

49

40

46

16

11

-7.2

-17.0

-0.5

13

4

32

25

59

33

0

Source: CIHI, Health Care in Canada, 2001.

Nursing is the largest health care profession.  In 1998, there were 7% fewer registered nurses and 17% fewer licensed practical nurses than in 1989.  Doctors are the third- largest group of regulated health care providers.  The number of physicians per Canadian in 1998 was about the same as ten years before, with only a slight decrease of about a half percent.  Other categories of health care providers (except optometrists) substantially expanded their workforce over the same period.  Although precise data are not available, an army of informal (volunteer) care providers provide some form of care to someone in their home with a long-term physical or mental illness or who is frail or disabled.  Information from CIHI (2001) suggests that the number of informal caregivers has increased over the past decade.

There are no straightforward answers to the question of how many people are currently needed in each field, and there is much less certainty with regard to future requirements.  Nevertheless, talk of a ‘crisis’ in health care has a good deal of plausibility in relation to human resource issues.  This is particularly true with regard to the situation facing registered nurses (RNs) in Canada.  But there are also shortages of other health care providers, in areas ranging from laboratory technologists to pharmacists.

Although it is more difficult to assess the overall situation with regard to physicians, there is nonetheless a long-standing problem of geographical distribution of physicians, with all rural and remote areas having great difficulty recruiting and retaining both general practitioners (GPs) and specialists. The geographic maldistribution of physicians is discussed in more detail in Chapter Ten.  As well, certain specialties are experiencing serious shortages.

Without an adequate supply of providers, health care will simply not be available to the extent that Canadians expect and deserve.  Questions concerning the supply, retention and management of human resources in health care are complex, broad and often overlapping, but they are of paramount importance in the context of ensuring the sustainability of Canada’s health care system.

Many of the key issues, such as the method and level of remuneration of health care providers, fall largely outside the purview of the federal government.  There are nonetheless other concerns - such as inter-provincial mobility, immigration, research funding, and taxation - in which federal policy plays a central role.  Because of the interaction between all these factors, it is important to get as complete a picture as possible of human resource issues so that the impact of possible policies at the federal level can be properly understood and assessed.

 

6.1     Physicians

6.1.1   Physician Supply

The extent to which there is a looming overall shortage of physicians in Canada remains a subject of debate.  Figures recently released by CIHI indicate that the number of physicians has increased in Canada over the past five years, from 54,918 in 1996 to 57,803 in 2000.[128]  However, while the total number of specialists increased by 7.4 percent, the number of family physicians only grew by 3.2%.  Since the Canadian population grew by 3.5 percent over the same period, the number of family physicians on a per capita basis actually declined slightly (from 95 per 100,000 population in 1996 to 94 in 2000).

Several witnesses stressed the importance of looking beyond the aggregate numbers.  Thus, despite the increase in the total number of specialists, witnesses indicated to the Committee that certain specialties are experiencing shortages.  For example, Dr. William Dalziel of the University of Ottawa estimated that there is a serious deficit of geriatricians.  Similarly, Dr. John Radomsky of the Canadian Association of Radiologists told the Committee that Canada currently has a shortage of about 200 radiologists, and that:

We simply do not have the manpower to provide the service. In my own practice, we have had to curtail service… to two small institutions because we do not have the manpower to provide them the service on-site. Patients have to travel. They are inconvenienced. In many cases they just do not do it.[129]

Witnesses told the Committee that physicians are already straining under the workload.  Dr. Peter Barrett, President of the Canadian Medical Association (CMA), pointed out that “the average physician in Canada is currently working 53 hours per week and an additional 25 hours per week while on call.”[130] Of even greater concern were the approximately 2,000 physicians who had no shared call, and were therefore “literally on call 24 hours per day, seven days per week, every day, every week, for years at a time.” [131]

Furthermore, the aging of the physician population means that many doctors are no longer willing or able to work the long hours that have become the norm. Dr. Barrett indicated that the average age of physicians rose from 46.4 to 47.5 between 1996 and 2000, and he added that “by 2024, 40 per cent of all active physicians will be over the age of 55.”[132]

At the same time, women have made tremendous strides in changing the profile of the medical profession.  Since the mid-1990s women make up over half of the medical students in the country,[133] and the percentage of practising female doctors increased from 25 to over 29 percent of the total between 1993 and 2000.  The Task Force on Physician Supply of the Canadian Medical Forum predicts that, by 2015, women will make up 40% of the physician supply.  However, data also indicate that female physicians practise fewer hours than their male counterparts, averaging 48.2 hours per week compared to the male average of 55.5 hours per week. [134]  As Dr. Barrett pointed out:

Women traditionally are more caring individuals and have tended to want a better balance in life. We are not seeing that only from the women, though. We are also seeing that from our younger graduates.[135]

6.1.2   Geographic Maldistribution

There was clear agreement during the Committee’s hearings on one subject:  the persistent geographic maldistribution of physicians across the country.  Over the past two decades, studies have repeatedly concluded that this longstanding problem has led to shortages of physicians in rural and remote areas.

Text Box: Rural Canada has 9 million people and is growing. It is scattered over 10 million square kilometres. The number of physicians serving this population is proportionately under half of that serving those in the cities.

Peter Hutten-Czapski, President, Society of Rural Physicians of Canada (17:12)

The problem seems to be getting worse, as an increasing number of smaller and medium-sized communities are finding it difficult to ensure a proper supply of physicians. As of October 1999, for example, 99 communities in Ontario had been designated as underserviced and were looking for a total of 534 physicians.[136]  Many factors have been identified as contributing to the difficulties in encouraging physicians to locate in underserved areas, including the heavy workload, the lack of training in skills needed for rural medicine, professional isolation and lack of interest in rural lifestyle.

The Committee heard evidence suggesting that physicians setting up their practices are more likely to choose rural or remote areas if they come from those backgrounds or if their training has exposed them to the positive challenges associated with locating in these areas.  Dr. Thomas Ward, chair of the Federal/Provincial/Territorial Advisory Committee on Health Human Resources, noted that “the single most important determinant as to whether an individual will work in a small community is if they are from a small community.”[137]

The supply of physician resources in rural Canada is discussed in more detail in Chapter Ten.

 

6.1.3   Physician Training and Recruitment

During the Committee’s hearings, witnesses discussed the issue of whether enough students are being admitted to Canada’s medical schools.

In 1991, a report by Barer and Stoddart recommended that enrolment in Canadian medical schools, along with positions in postgraduate training positions, be decreased by 10% in order to deal with a perceived unwarranted increase in physician supply.[138]  Despite the report’s admonishments that this recommendation not be implemented in isolation from the others it proposed[139] (53 in all), policy-makers did precisely that.  As a result, according to data from the Association of Canadian Medical Colleges, the size of first year classes in medical colleges has declined by 16 percent since 1991.

The first-year enrolment in 1997-98 of 1,577 students, or approximately 1 per 19,000 citizens, put Canada well behind other industrialized countries such as the United Kingdom (1 per 12,200 citizens) or Australia (1 per 13,500).  According to Dr. Hugh Scully, President of the Task Force on Physician Supply, Canadian Medical Forum: “by 1997, there was less opportunity for a Canadian to go to medical school than for any person in any other developed country in the world for its population.”[140]  Although by early 2001 announced increases to undergraduate enrolment totalled 228 new places (a 14 percent increase over 1998) this is still below the entry level of 1983 (the peak year).[141]

While recognizing that “that there has been more movement on the part of the medical schools and the establishment in the last 18 months than in the last 20 years,”[142] Dr. Scully insisted that more progress cannot be made unless additional resources are put into the system, telling the Committee that:

If we are to have the teachers to do the work and the resources, both capital and physical, that we need, there needs to be some infusion. We think that the federal government can play a significant role in partnership with the provinces and the territories.[143]

Canada also does not offer as many postgraduate training positions as other countries, with 100 provincially-funded positions for each 100 graduates (compared to 129/100 in the United States and 140/100 in Britain).  Dr. Scully pointed out that “we once had a much better capacity than we have at the present time to validate the international graduates who were qualified.”[144]

In the past, Canada has been able to rely on recruitment from abroad to fill some of the gaps.  International medical graduates (imgs) have made significant contributions to Canadian health care.  Currently, almost 25 percent of Canada’s physicians received their undergraduate (MD) training outside Canada.  Imgs are unevenly distributed geographically and by specialty, accounting for only 12 percent of supply in Quebec but about 50 percent in Saskatchewan.  One third of pediatricians, but only 22% of family practitioners are imgs.

The United Kingdom has been the major source of imgs.  However, other countries now face many of the same shortages that confront our health care system, and there does not seem to be much sense to countries endlessly poaching each other’s highly trained health care professionals.  Dr. Scully insisted on this point:

Canada traditionally would draw upon the U.K., South Africa, and some of the European countries for its medical graduates. That source has in large part stopped, not all together. Those countries are working earnestly to try to retain their own physicians and make it attractive for them to stay. The sources that we have had are not there.[145]

Rising tuition fees constitute a major barrier to medical enrolment.  Dr. Barrett stated that:

(…) tuition deregulation has meant that tuition for our students is becoming prohibitive. If we do not do something soon, it will only be the sons and daughters of wealthy Canadians who will be able to go to medical school and choose a career in medicine.[146]

The Committee was told that rising tuition fees are of great concern for students from rural Canada.  For example, Dr. Thomas Ward, Chair of the F/P/T Advisory Committee on Health Human Resources, stated:

We have seen a dramatic swing in the past four years, in our province, in the distribution of people coming into the medical school. As university tuition has gradually risen, university medical schools are a cash cow for most universities, quite frankly. We have seen that the percentage of students coming from rural Nova Scotia is dropping steadily.[147]

Dr. Barrett expressed similar concerns in relation to the recruitment of medical students from Canada’s Aboriginal populations:

I will give you an example from my province of Saskatchewan, where we have a huge Aboriginal population. The best way to deliver health care to them would be, especially in consideration of their culture, to have First Nation's health care providers. However, right now our system has barriers that hinder their receiving the necessary education. That is why we need to look at the whole area of post-secondary education. In particular in consideration of tuition deregulation, we must examine who we are educating today.[148]

 

6.1.4   The “Brain Drain”

Another controversial issue concerns the ‘brain drain’ of physicians, particularly to the United States.  Table 6.2 gives figures for the departure and return of physicians.  During the period between 1996 and 2000, the number of physicians leaving the country declined significantly, from 1.3 percent of the total physician supply in 1996 to 0.7% in 2000.  Of these physicians, the majority were male, specialist physicians.  Almost half received their M.D. within the past 10 years.  The number of physicians who returned from abroad increased somewhat over the 1996-2000 period.  Overall, fewer doctors are leaving and more are entering Canada (except for 2000).  However, Canada still experiences a net loss year after year.

The international migration of physicians remains a major concern for many witnesses.  Dr. Barrett said that “for every 19 physicians that go south, one comes north,”[149] while Dr. Scully pointed out that “we continue to lose two medical class school equivalents a year as a net loss to the United States.”[150]

Table 6.2

Physicians Moving Abroad and Returning to Canada, 1996-2000

 

Moving Abroad

Returning

Net Loss

1996

726

218

508

1997

658

227

431

1998

568

319

249

1999

584

340

244

2000

420

256

164

Source: CIHI, Supply, Distribution and Migration of Canadian Physicians, 2000 Report, Executive Summary,
9 August 2001 (available at http://www.cihi.ca).

While clearly many factors clearly influence decisions by Canadians to relocate elsewhere, it has sometimes been contended that Canada’s more onerous tax regime drives high-earners to seek more favourable circumstances south of the border.  Surveys among doctors, however, indicate that income is usually not the prime motivator for leaving Canada, and that the conditions under which they are able to practise their profession rank higher as a factor.  Dr. Scully argued very much along these lines:

The money is no different in Alberta than North Dakota. It is not a question of money. It is the facility to take care of your patients’ welfare. If we want to attract and retain physicians, we need to work together to ensure that the facilities are there so that physicians, nurses and others can work to provide the services that are needed by people.[151]

In the same vein, Dr. Barrett stated:

Like other sectors of the economy, if we are going to compete and succeed, we must provide an attractive environment to not only retain but repatriate the physicians who have left. If we are serious about a world class health care system in Canada, we must provide an environment that will attract world-class people and retain the world class people that we train.[152]

Overall, all witnesses agreed that what was needed was a comprehensive human resources plan.  As Dr. Scully pointed out, “there are no quick answers or quick fixes.”[153] In Dr. Barrett’s words:

We could start with a national strategy because it is a national problem. I realize a lot of health care is delivered provincially and territorially. First and foremost, we need a national plan.[154]

 

6.2     Nurses

Nurses constitute the largest group of health care providers in Canada, making up almost two-thirds of the total.  There are three regulated nursing groups: registered nurses (RNs), licensed practical nurses (LPNs – also known as Registered Nursing Assistants and Registered Practical Nurses), and Registered Psychiatric Nurses (RPNs).  Most of the available data refers to the situation of RNs.  There are two routes to qualification as an RN: (i) diploma programs offered at community colleges, and (ii) baccalaureates of Science in Nursing at the university level.  Around 90% of nurses employed in nursing have a basic diploma education.  Some provinces recognize an additional extended classification of nurses, usually referred to as nurse practitioners, but there are no national standards in place, and the term is not a protected designation.

Nurses work in a great variety of settings and perform a wide array of tasks requiring a considerable diversity of skills, ranging from assisting in the treatment of acutely ill patients in a hospital setting, to planning and monitoring home care programs, to organizing and delegating workloads.  Recent changes in the organization and delivery of health care have had a significant impact on the types of work being done by nurses and on the numbers of nurses available to perform them.

With the shift towards shorter hospital stays, nurses are treating more acutely ill patients as well as being asked to perform many tasks that might have been done previously by other hospital staff.  For example, a recent study indicates that in Canada over 42% of nurses report performing housekeeping duties, while a similar number (43.6%) report that such essential nursing tasks as comforting or talking with patients are being left undone.[155]  Trends in health care technology also mean that nurses must accomplish more complex tasks, under great stress and with shrinking resources. In this regard, Kathleen Connors, President of the Canadian Federation of Nurses Unions, told the Committee that nurses:

(…) want to nurse in the way that they were educated to nurse. Not only do they want to perform the physical parts of the care, they also want to teach and take the time to sit on the side of the bed of someone who needs to be supported and comforted. They want to counsel, nurture and do all those things on which it is difficult to place a monetary value.[156]

 

6.2.1   Supply of Nurses

CIHI reports a decline of 7.2% in the number of RNs (per 100,000 Canadians) employed in nursing between 1989 and 1998, while the number of LPNs declined by 17% over the same period (see Table 6.1).  According to the Canadian Nurses’ Association, there is looming crisis in the supply of qualified nursing personnel.  The Association forecasts a shortfall of at least 59,000 nurses in Canada by 2011, but that this shortfall could be as high as 113,000 if all the needs of an aging population are taken into account (Table 6.3).

Text Box: The importance and focus of addressing the nursing health human resource issue is imperative.  We ignore it at the peril of our health care system.  That is the message that we cannot state any more passionately to you as a committee looking at the future of our health care system.

Kathleen Connors, Canadian Federation of Nurses Unions (13:79)

Table 6.3

number of employed Registered Nurses needed to adequately meet demands in 2011

Projected level of demand

Needed

Available

Deficit

Low

290,000

231,000

59,000

Medium

317,000

231,000

86,000

High

344,000

231,000

113,000

Source: Statistical picture of the past, present and future of RNs in Canada, CNA, 1997.

While witnesses acknowledged that the nursing shortage is worldwide in nature (with only Hong Kong registering a surplus of nurses[157]), they also indicated that the severity of the situation facing nursing in Canada had its origins in the cost containment strategies that were initiated by all governments across the country in the early 1990s. For this reason, they unanimously recommended that more funds be invested in the health care system so that the shortage in nursing resources could be redressed.  For example, Régis Paradis, President of the Ordre des infirmières et infirmiers auxiliaires du Québec, argued that “even if the federal government had to take various steps to put its fiscal house in order, we believe that the cuts have been too drastic, carried out without meaningful consultation and also without taking into account the real needs of the public.”[158]  Similarly, Sandra MacDonald-Remecz, Director of Policy, Regulation and Research at the Canadian Nurses Association (CAN), affirmed to the Committee:

If I were to leave with you any message, it is that I believe that investing is extremely important. We need to invest so that we can have the kind of qualified, competent worker within our health system. If you do not have that competent, qualified person, you do not have a health system.[159]

 

6.2.2   Working Conditions

The shortage of nurses has important consequences both for the delivery of health care and for the working conditions faced by health care providers who have to try to cope with fewer available people.  Kathleen Connors noted that “Canada is suffering a nursing shortage that regularly closes emergency rooms and shuts operating rooms,”[160] and added:

Shifts piling on top of each other take their toll on nurses who might be taking care of your mom or your child. In some cases, we are doing so having worked more than 60 hours in the week… Flight attendants have mandatory time off, but nurses do not. In the end, that is not good for nurses and it definitely is not good for those for whom we care.[161]

Despite the overall shortage of nursing personnel, full-time employment for nurses has become less common.  Sandra MacDonald-Remecz told the Committee that “the period that we have gone through saw a significant move to part-time and casual status.”[162]  In fact, the number of nurses working part-time increased by almost 10% between 1990 and 1997 while those in full-time positions declined by about 8.5%.  There was also a 37.5% increase in the number of nurses working as casuals over the same period.  While it is no doubt true that some nurses prefer part-time work, nonetheless about 19% of nurses employed part-time in 1998 held down more than one job, and very few nurses voluntarily choose casual work.[163]

The “casualization” of the workforce has also meant that it is increasingly difficult for new nursing graduates to secure permanent positions.  This tends to reduce the attractiveness of nursing as a career choice and to prolong the apprenticeship period of new graduates.  In this regard, Kathleen Connors pointed out that:

The situation facing those younger nurses is that of casual or part-time employment opportunities – working for several employers, instead of working full-time for one employer. In 1998, 48 per cent of all nurses in Canada were working part-time. It just should not be.[164]

According to witnesses, this contributes to a situation where 3 in 10 nurses leave the profession in the first five years after graduation.[165]

This combination of an overall shortage of nursing personnel and under-utilization of trained nurses is also evident with regard to other categories of nursing personnel.  For example, Linda Jones from the Nurse Practitioners Association of Ontario told the Committee that “of our 401 graduates, 200 of them are under- or poorly employed as nurse practitioners.”[166]  Similarly, Régis Paradis indicated that, “we (…) consider that the skills of Quebec auxiliary nurses are not being fully used,”[167] and that “the solution to the problem of work overload, in addition to putting more money into the system, lies partly in making more use of auxiliary nurses.”[168]

But the deterioration in working conditions for nurses extends beyond the full utilization of the different categories of nursing personnel.  According to CIHI, nurses account for over 75% of workplace injuries in health care, stemming mainly from lifting and moving patients.  During her testimony, Kathleen Connors indicated that:

(…) nurses are sicker than any other worker in the country.  In fact, 8.4 percent of nurses are absent from work due to illness each week.  That is twice the national average.[169]

Witnesses also raised concerns that there are many ways in which nurses are not being accorded the respect they deserved for their essential contribution to the health care system.  Amongst the issues that have been raised as critical to retaining nurses in the profession are appropriate workload, adequate continuing education, career mobility, flexible scheduling and deployment, professional respect and good wages. Witnesses argued that what is needed to retain nurses in the profession in Canada is a comprehensive approach to ensuring a healthy work environment that also allows nurses sufficient autonomy in carrying out their duties and room for ongoing professional development.  The Canadian Nurses Association identified seven areas of action needed to retain nurses:

·        Improve work design

·        Facilitate use of full scope of practice

·        Provide support for professional development and continuous learning via taxes, training and time

·        Identify career opportunities and offer career planning

·        Support flexible scheduling

·        Provide accessible professional supports

·        Improve access to research on clinical disease issues and provide time to review and stay up-to-date.

 

6.2.3   Training and Recruitment in Nursing

The Committee was told that there are many difficulties in recruiting enough young people to train as nurses.  Witnesses contended that nursing, which remains an overwhelmingly female profession,[170] is no longer as attractive a career option for young women entering university as it was for the previous generations.  Sandra MacDonald-Remecz noted that “we have seen a 50 per cent reduction in the number of graduates in nursing over the last 10 years.”[171]

Figures indicate that not only are fewer new nurses entering the profession each year, but those that do are older than previously. The number of new nurses graduating each year was in the 10,000 per year range in the 1970s and in the 8,000 per year range in the 1980s.  Since then, each class has become increasingly smaller and only 5,500 nurses graduated in 1995.  Witnesses pointed to the solution adopted in the Republic of Ireland, where they waived all tuition fees for nursing students, as being worthy of emulation.

The issue of continuing education for nursing was also raised at the Committee’s hearings.  The lack of opportunity for ongoing education was pointed to as part of the problem explaining the attraction of new graduates in nursing to the United States.  While no exact figures are available, some media reports have suggested that as many as 20,000 Canadian nurses have been recruited by American hospitals.  According to Sandra MacDonald-Remecz:

(…) when we look at why the Americans are so successful in recruiting our new graduates, we see that it is because they promise continuing education opportunities right from the time they sign on.” [172]


One way of facilitating ongoing education was suggested by Kathleen Connors:

(…) one of the issues that we continue to promote and hope that there will be support for, is the use of employment insurance dollars. There is a surplus. If skilled trades can access EI dollars to continue to advance their education, why can nurses not do the same thing? We need to look at that. Why does EI prevent access of dollars for post-secondary education?[173]

Another solution was proposed by Ms. MacDonald-Remecz:

Signing bonuses are another incentive - which, in a field like health care it sounds almost heretical to be taking on that kind of orientation. However, it is something that many organizations are realizing that they may need to do. In other words, we need to be more aggressive and recognize that people will not just naturally come into the profession.[174]

 

6.3     Other Health Care Providers

Many other health care providers, from pharmacists to laboratory technologists to ultrasound technicians, have voiced similar complaints to the ones expressed by physicians and nurses over human resource shortages and deteriorating working conditions throughout Canada’s health care system.

For example, the Canadian Society for Medical Laboratory Science (CSMLS) predicts a nation-wide shortage of general medical laboratory technologists within the next 5 to 15 years.  Moreover, medical laboratory technologists are aging:  12% of the current workforce will be eligible to retire in 5 years, 15.8% in 10 years and another 16.6% in 15 years.  By the year 2015, 44.4% of the medical laboratory workforce will either have retired or will be eligible to retire.[175]  In its brief, the Society stressed that the number of training positions would have to be increased significantly to avert the shortage of technologists.  Medical laboratory technologists also stressed the need for ongoing training to enable them to operate new high-tech equipment.  Moreover, the medical laboratory workforce is also experiencing high levels of burnout and fatigue.  Finally, the establishment of a national data base was recommended to develop accurate projections of future human resource requirements in health care.

Text Box: Chiropractors are mostly neuro-musculoskeletal physicians. They are currently unable to utilize all the tools of the profession and are hampered clinically. We are denied hospital access, sometimes unable to treat lifelong patients who become institutionalized. We are denied x-ray access and access to blood and urine analysis.

Dr. Tim St. Denis, President, Canadian Chiropractic Association (13:85)

The Canadian Pharmacists Association also pointed to a current shortage of pharmacists.  This shortage is not unique to Canada, but is a problem faced in many countries including the United Kingdom and the United States.  The low supply of pharmacists translates into increased numbers of vacancies, longer times to fill vacancies, increases in overtime hours, and wages rising in excess of the cost of living.  A recent study suggests that well over 2,000 additional pharmacists could readily find work in Canada.[176]  In the context of the growing evidence of drug-related complications, an aging population, and rising public expectations, it is anticipated that pharmacists will be increasingly valued and demanded for their knowledge, skills, and cost-effective contribution to the health care system.  The study also mentions that currently available information offers an incomplete picture of the labour market for pharmacists.

Chiropractors’ representatives told the Committee about their particular situation.  Chiropractic services are not considered as medically necessary under the Canada Health Act.  Only a few provinces provide public insurance for chiropractic services.  The Committee was told that there are over 5,000 practising chiropractors in Canada and that approximately 4.5 million Canadians use their services every year.  In its brief, the Canadian Chiropractic Association stated that chiropractors are not being utilized by Canada’s health care system in the most effective way.  There are policy and legislative barriers to chiropractic services which result in inequitable resource allocation irrespective of patient choice, efficacy or cost-effectiveness.  For example, chiropractors do not have hospital privileges, they cannot refer their patients to publicly supported X-ray facilities or diagnostic laboratories, or render services to their patients who may require hospitalization.

 

6.4     Primary Care Reform

Testimony before the Committee by health care providers, particularly physicians and nurses, clearly indicated that a more rational and efficient use of human resources requires a rethinking of the organization and the funding of primary health care delivery in Canada.

“Primary health care” refers to the first level of care, and is usually the first point of contact that people have with the health care system.  Primary health care settings support individuals and families to make the best decisions for their health.  Primary health care services need to be:

·        coordinated;

·        accessible to all consumers;

·        provided by health care professionals who have the right skills to meet the needs of individuals and communities being served; and

·        accountable to local citizens through community governance.

Multidisciplinary teamwork must therefore be a vital part of primary health care.  The goal of this teamwork is not to displace one health care provider with another, but rather to look at the unique skills each one brings to the team and to coordinate the deployment of these skills.  Clients need to see the health care provider who is most appropriate to deal with their problem.

The way in which health care is currently delivered in Canada does not normally reflect a primary health care philosophy (although Community Health Centres are an example of organizations that do deliver health services using such a philosophy).  Health services are often not coordinated, nor are they being provided by the most appropriate practitioner; as well, the knowledge and skills of many practitioners are not being fully utilized.

The need for significant changes to the way primary health care is delivered has been the principal thrust of the recommendations of a number of provincial health care reviews, notably the Sinclair Commission Report in Ontario, the Clair Commission Report in Quebec and the Fyke Commission Report in Saskatchewan.  In fact, the importance of changing the way primary health care is delivered is so widely established that, in September 2000, provincial and territorial governments all agreed to accelerate primary health care renewal.

The federal government is actively supporting the efforts of provinces and territories in primary health care reform and renewal.  More precisely, it has established a Primary Health Care Fund of $800 million over four years (2000-2004) to support the transitional costs of implementing systemic, large-scale, primary health care initiatives.  Some 70% of the funds are to be devoted to major provincial and territorial reforms, while the remaining 30% is going to support national and multi-jurisdictional initiatives related to advancing primary health care reform.

Dr. Thomas Ward indicated that Canadians and physicians support the idea of moving towards multidisciplinary primary care teams:

There was a survey last fall in which, when Canadians were asked if they would rather receive their care from a family physician or from a primary care team that included a family physician, their response was 4 to 1 in favour of the team. They would much rather have a team of health care providers. Our vision for the future is full integration wherever primary health care is provided through practising within interdisciplinary teams.[177]

The Committee was also told that reform of primary care is clearly central to the possibility for the full deployment of the additional skills possessed by nurse practitioners.  Primary health care nurse practitioners are experienced registered nurses with additional nursing education that enables them to provide individuals, families and communities with health services in the areas of health promotion, disease and injury prevention, cure, rehabilitation and support.  Their skills include the ability to: provide health screening activities such as PAP smears; to diagnose and treat minor illnesses such as ear and bladder infections or minor injuries such as sprains; to screen for the presence of chronic disease such as diabetes; and to monitor people with stable chronic disease such as hypertension.  They function within the full scope of nursing practice and are neither second-level physicians nor doctor’s assistants.  As Linda Jones, from the Nurse Practitioners Association of Ontario, said:

A very important…point is the lack of public understanding of the role, impacts and utilization of nurse practitioners. If we are seen as physician replacements – you cannot see your family doctor, you must see your nurse practitioner instead – that will not enhance or increase public acceptance of us.[178]

While nurse practitioners are an important part of primary health care reform, there remain considerable barriers to their full integration into the system of primary health care delivery.  Ms. Jones pointed out that, in Ontario:

The existing legislation, although we are incredibly excited about the fact that we now have our own autonomy to do our role, leaves us with barriers. For example, the public hospitals act does not allow us to perform our role in hospitals.[179]

The Committee was told that the barriers are not exclusively legislative or organizational, however.  They are also created by the way that money is distributed throughout the health care system, and, in particular, by the overwhelming reliance on fee-for-service payment as the main method for remunerating physicians.  Fee-for-service tends to actively discourage physicians from promoting teamwork, as their individual remuneration depends on the number of patients they see.  In her testimony, Linda Jones pointed to another way that fee-for-service payment prevents full collaboration amongst health care providers:

(…), although we have skills and knowledge to refer to medical specialists, the current payment system under OHIP does not give a specialist the full consulting fee if the referral comes from nurse practitioners. Therefore, they decline our referrals.[180]

The main alternatives to fee-for-service payment are salary- and capitation-based systems, where physician practices are remunerated based on the number of registered patients.  William Tholl, Secretary General and Chief Executive Officer of the Canadian Medical Association (CMA), told the Committee that physicians are willing to consider other forms of remuneration:

The CMA would suggest, as I would also suggest, that the form of payment should follow the functions that you identify for the physician in the system. Clearly, physicians and other health professionals working in rural and remote areas have a different function in the system as compared to those that work in downtown Toronto.[181]

 

6.5     Committee Commentary

The Committee is convinced that addressing the issues relating to human resources in health care must be amongst the top health care policy priorities for all levels of government.  What is needed is a country-wide, long-term, made-in-Canada, human resources strategy.  The federal government could play an important role in coordinating and implementing such a strategy.  Of course, not only do the provinces and territories have the responsibility for the delivery of health care to their populations, they are also responsible for education and training.  The challenge is therefore to find a way to develop such a strategy in a manner that is acceptable to the provinces and territories.

In the past, the federal government has contributed capital funds toward the creation of new health services training programs, notably in the 1960s when it was involved in the expansion of a number of medical schools.  The federal government has also contributed to training programs for some health professionals under the various federal training programs which have existed over the years.  Moreover, the federal government, through its support for such institutions as the Medical Research Council and now the Canadian Institutes for Health Research, has helped support graduate students pursuing health research for more than 40 years.

It is important that the federal government continue this involvement in order to help resolve the many health care human resource challenges facing the country.  This includes assisting the provinces in their efforts to reform primary health care, because ways of effectively deploying human resources are intimately tied to the reorganization of primary health care.



[1] Debates of the Senate (Hansard), 2nd Session, 36th Parliament, Volume 138, Issue 23, December 16, 1999.

[2] David Cheal, “Aging and Demographic Change,” Canadian Public Policy. Vol. XXVI, supplement 2, August 2000, p. S110.

[3] Statistics Canada, CANSIM, Matrix 6367.

[4] Réjean Lachapelle and Jean-Marie Berthelot, Brief to the Committee, 21 March 2001, p. 2.

[5] Abby Hoffman (7:19).

[6] Byron G. Spencer, Brief to the Committee, 22 March 2001, p. 7.

[7] These four schools of thought are well summarized in: Canadian Medical Association, In Search of Sustainability: Prospects for Canada’s Health Care System, August 2000.

[8] Conference Board of Canada, Brief to the Committee, 21 March 2001, p. 5.

[9] William Robson, Will the Boomers Bust the Budget?, Brief to the Committee, 21 March 2001.

[10] Dr. Michael Gordon, NACA, Brief to the Committee, 21 March 2001, p. 5. In fact, a number of factors influence the average length of stay in hospital including advances in surgical and other procedures, the greater range and efficacy of available drugs, as well as more sophisticated approaches to convalescence.

[11] Byron Spencer, Brief to the Committee, p. 1.

[12] See, for example, a report by the Office of the Auditor General of Canada, Population Aging and Information for Parliament: Understanding the Choices, Chapter 6, 1998 Report.

[13] William Robson (3:5).  In this report, the testimony received by witnesses printed in the Minutes of Proceedings and Evidence of the Standing Senate Committee on Social Affairs, Science and Technology will be hereafter referred to only by issue number and page number within the text.

[14] Byron Spencer (3:30).

[15] Byron Spencer (3:16).

[16] Jean-Marie Berthelot (2:11).

[17] Ibid.

[18] Jean-Marie Berthelot (2:10).

[19] Lachapelle and Berthelot, Brief to the Committee, p. 4.

[20] Rob Brown (2:15).

[21] Abby Hoffman (7:7).

[22] Dr. Michael Gordon (2:39).

[23] Health Canada, Brief to the Committee, slide 6.

[24] Dr. Michael Gordon, Brief to the Committee, p. 2.

[25] Byron Spencer (3:36).

[26] Dr. Michael Gordon (2:38).

[27] Ibid.

[28] Dr. William Dalziel (3:18).

[29] Dr. William Dalziel (3:12).

[30] Dr. William Dalziel (3:10).

[31] William Robson (3:7).

[32] Byron Spencer, Brief to the Committee, p. 5.

[33] Spending on drugs reported by the CIHI includes prescription drugs, OTC products and personal health supplies, but does not include drugs dispensed in hospitals and other institutions.

[34] Report of the Federal/Provincial/Territorial Task Force on Pharmaceutical Prices, Drug Prices and Cost Drivers 1990-1997, April 1999, pp. 13-14.

[35] PMPRB, Annual Report 2000, p. 15.

[36] Ibid., p. 16.

[37] Ibid., p. 17.

[38] Ibid.

[39] Ibid.

[40] Ibid., p. 23.

[41] Canadian Pharmacists Association, Health Care Delivery, Optimizing Drug Therapy and the Role of the Pharmacist, Brief to the Committee, March 2001.

[42] Dr. Roger A. Korman (4:15).

[43] Ibid.

[44] Ibid., 4:16.

[45] A description of provincial cost controls can be found in the Institute of Health Economics Working Paper 00-2, Public Policies Related to Drug Formularies in Canada: Economic Issues and Devidas Menon, “Pharmaceutical Cost Control in Canada: Does It Work?”, Health Affairs, Vol. 20, No. 3, May/June 2001.

[46] PMPRB (2000), p. 18.

[47] Ibid., p. 26.

[48] Ibid., p. 21.

[49] Drug Prices and Cost Drivers 1990-1997 (1999), p. 30.

[50] Ibid., p. 34. Nova Scotia was not included.

[51] Ibid., p. 35.

[52] Ibid.

[53] Ibid., p. 36.

[54] The Fraser Institute, “Prescription Drug Prices in Canada and the United States,” Public Policy Sources, August 2000.

[55] Drug Prices and Cost Drivers – 1990-1997 (1999), p. iii.

[56] Report of the Federal/Provincial/Territorial Task Force on Drug Utilization, Drug Utilization in Canada, April 1999, p. 1.

[57] Dr. Robert Coambs (4:9).

[58] Dr. Roger A. Korman (4:17).

[59] Canadian Association of Gerontology, Policy Statement: Seniors and Prescription Drugs, 1999, (http://www.cagacg.ca/english/pubs/pol-drugs.htm).

[60] Coambs, Robert B., Ph.D. et al., Review of the Scientific Literature on the Prevalence, Consequences, and Health Costs of Non-Compliance and Inappropriate Use of Prescription Medications in Canada, PMAC, 1995.

[61] Dr. Jeffrey Poston (4:11-12).

[62] Ibid. (4:13).

[63] Ms. Barbara Ouellet (4:20).

[64] Dr. Jeffrey Poston (4:13).

[65] Canadian Life and Health Insurance Association, Drug Expense Insurance in the Canadian Population, 1998.

[66] The summary description of government and private plans has been taken from information contained in the study Canadians’ Access to Insurance for Prescription Medicines, Applied Management in Association with Fraser Group, Trisat Resources, Study submitted to Health Canada under the Health Transition Fund, March 2000.

[67] Canadians’ Access to Insurance for Prescription Medicines, Executive Summary Applied Management in Association with Fraser Group Trisat Resources, Study submitted to Health Canada under the Health Transition Fund, March 2000.

[68] These conclusions are summarized in the study’s Executive Summary.

[69] Robyn Tamblyn, et al., Evaluation Report of the Impact of Prescription Drug Insurance Plan, Summary, March 1999.

[70] Ibid., p. 22.

[71] Dr Robert Coambs (4:21).

[72] Palmer d’Angelo Consulting Inc., National Pharmacare Cost Impact Study, September 1997.

[73] Dr. Joel Lexchin, A National Pharmacare Plan: Combining Efficiency and Equity, Canadian Centre for Policy Alternatives, March 2001.

[74] 41st Annual Premiers’ Conference, “Premiers’ Commitment to their Citizens,” News Release, Winnipeg, 11 August 2000 (also available at http://www.scics.gc.ca/cinfo00/850080017_e.html).

[75] Barbara Ouellet (4:41).

[76] David Feeny, The Generation, Evaluation and Application of Health Care Technologies in Canada.  Brief to the Committee, 29 March 2001, p. 5.

[77] Experts often include the innovative ways to finance, organize and provide health care under the category of disembodied health care technology.

[78] Dr. John Radomsky, CAR (5:32).

[79] David Feeny, Brief to the Committee, pp. 5-6.

[80] British Columbia Medical Association, Turning the Tide – Saving Medicare for Canadians, Part I of II: Laying the Foundation for Sustaining Medicare, Background Paper, July 2000, pp. 31-34.

[81] Konrad Fassbender and Melinda Connolly, An Empirical Review of Health Expenditures and Technology – Part 2 of 5: Literature Review,  Institute of Health Economics, University of Alberta, Working Paper Series no. 00-08, 2000 (http://www.ipe.ab.ca).

[82] Dr. Paul R. Gully, Infectious disease trends in Canada, Brief to the Committee, 4 April 2001, p. 2.

[83] Dr. Paul Gully, Brief, p. 5.

[84] Dr. Paul Gully (6:10-11).

[85] Dr. Christina Mills, Chronic Diseases and Injuries in Canada, Brief to the Committee, 4 April 2001, p. 4.

[86] Dr. David MacLean, Addressing the Burden of Chronic Disease in Canada, Brief to the Committee, 3 April 2001, p. 1.

[87] Dr. David MacLean (6:14).

[88] Dr. David MacLean, Brief to the Committee, p. 4.

[89] Dr. David MacLean (6:16).

[90] Federal/Provincial/Territorial Advisory Committee on Population Health, Toward a Healthy Future – Second Report on the Health of Canadians, Ottawa, 1999, p. 19.

[91] Dr. Christina Mills, Brief to the Committee, p. 10.

[92] Kimberly McEwan and Elliot Goldner, Accountability and Performance Indicators for Mental Health Services and Supports: A Resource Kit, prepared for the Federal/Provincial/Territorial Advisory Network on Mental Health, Ottawa, Health Canada, 2000, p. 30.

[93] Dr. David MacLean, Brief to the Committee, p. 3.

[94] Dr. Christina Mills (6:6 and 6:8).

[95] Dr. Christina Mills (6:7).

[96] Dr. David MacLean, Dalhousie University (6:25).

[97] Christina Mills (6:9).

[98] Paul Gully (6:26).

[99] The demographic information comes from the following three publications: Indian and Northern Affairs Canada and Canadian Polar Commission, Estimates Part III, 2000-2001; Statistics Canada, 1996 Census: Aboriginal Data; Health Canada, A Second Diagnostic on the Health of First Nations and Inuit People in Canada, November, 1999.

[100] Indian and Northern Affairs Canada and Canadian Polar Commission, Estimates 2000-2001, Part III, Report on Plans and Priorities, p. 4.

[101] The information relating to the socioeconomic conditions and the physical environment comes from the following publications, unless otherwise indicated. Federal, Provincial and Territorial Advisory Committee on Population Health, Toward a Healthy Future, Second Report on the Health of Canadians, 1999, Statistics Canada, 1966 Census: Aboriginal Data; Royal Commission on Aboriginal Peoples, Final Report,  1996; Health Canada, A Second Diagnostic on the Health of First Nations and Inuit People in Canada, November 1999.

[102] The report also pointed out that these figures likely underestimate the Aboriginal data because some 44,000 people living on reserves and settlements were incompletely enumerated in the 1996 census. 

[103] A Second Diagnostic on the Health of First Nations and Inuit People in Canada, November, 1999, p, 14.

[104] Ibid., p. 14-18.

[105] Sources include: Federal/Provincial/Territorial Working Group on Aboriginal Peoples and HIV/AIDS, Making a Difference, May 1999; Federal, Provincial and Territorial Advisory Committee on Population Health, Toward a Healthy Future: Second Report on the Health of Canadians, 1999; Jill Lava and Michael Clark, Diabetes Among Aboriginal (First nations, Inuit and Métis) People in Canada: The Evidence, 10 March 2000; First Nations and Inuit Regional Health Survey National Report 1999; Health Canada, A Second Diagnostic on the Health of First Nations and Inuit People in Canada, November, 1999; Assembly of First Nations, Brief to the Committee, 30 May 2001; Inuit Tapirisat of Canada, Evaluation of Models of Health Care Delivery in Inuit Regions, 2000; Mr. Gerald Morin, President, Métis National Council, 30 May 2001 (16:29-33).

 

[106] Making a Difference, Report of the Federal/Provincial/Territorial Working Group on Aboriginal Peoples and HIV/AIDS, May 1999.

[107] Health Canada, Brief to the Committee, 30 May 2001; Margaret Horn, National Indian and Inuit Community Health Representatives Organization, Brief to the Committee, 30 May 2001.

[108] National Aboriginal Health Organization, Brief to the Committee, 30 May 2001, p. 1.

[109] Inuit Tapirisat of Canada, Evaluation of Models of Health Care Delivery in Inuit Regions, 2000, p. 10.

[110] Ibid., pp. 9-10.

[111] Ibid.

[112] Ian Potter (16:8-9).

[113] Ibid.

[114] National Aboriginal Health Organization, An Examination of Aboriginal Health Service Issues and Federal Aboriginal Health Policy, Brief to the Committee, 30 May 2001, pp. 4-5.

[115] NAHO, Brief to the Committee, 30 May 2001, p. 5. These initiatives include Aboriginal Diabetes Initiative, Aboriginal Healing Foundation, National Aboriginal Health Organization, Aboriginal Head Start.

[116] Ibid. pp. 7-8.

[117] Dr. Judith Bartlett (16:58-59).

[118] Mr. Gerald Morin (16:31).

[119] Ibid., p. 9.

[120] NAHO, Brief to the Committee, p. 9.

[121] Ibid., p. 7.

[122] Ron Wakegijig, Brief to the Committee, 30 May 2001, p. 9.

[123] Pauktuutit Inuit Women’s Association of Canada, Presentation to the Standing Senate Committee on Social Affairs, Science and Technology, May 30, 2001, p. 2.

[124] Elaine Johnson (16:26).

[125] Assembly of First Nations, Brief to the Committee, 30 May, p. 5.

[126] Ibid., p. 8.

[127] Dr. Jeff Reading (16:61-62).

[128] CIHI, Supply, Distribution and Migration of Canadian Physicians, 2000 Report, Executive Summary, 9 August 2001 (available at http://www.cihi.ca).

[129] Dr. John Radomsky (5:7).

[130] Dr. Peter Barrett (13:6).

[131] Ibid.

[132] Dr. Peter Barrett (13:8).

[133] The Association of Canadian Medical Colleges, Canadian Medical Education Statistics, Vol. 22, 2000, Table 8, p. 11.

[134] Canadian Medical Forum, Task Force on Physician Supply in Canada, 22 November 1999, p. 11.

[135] Dr. Peter Barrett (13:8).

[136] Dr Robert McKendry, Physicians for Ontario: Too Many? Too Few? For 2000 and Beyond, p. vii.

[137] Dr. Thomas Ward (13:37).

[138] Morris L. Barer and Greg L. Stoddart, Toward Integrated Medical Resource Policies for Canada, Prepared for the F/P/T Conference of Deputy Ministers of Health, June 1991.

[139] The report stated: “isolated policies on undergraduate medical school enrolment may do more harm than good if they are not combined with appropriate companion policies concerning graduates of foreign medical schools, financing of academic medical centres, residency training, and quality assurance, to name only a few.” See p. 6.

[140] Dr. Hugh Scully (13:11).

[141] Canadian Medical Forum, Brief to the Committee, 16 May 2001, p. 3.

[142] Dr. Hugh Scully (13:19).

[143] Dr. Hugh Scully (13:14).

[144] Dr Hugh Scully (13:12).

[145] Dr. Hugh Scully (13:17).

[146] Dr. Peter Barrett (13:9).

[147] Dr. Thomas Ward (13:36-37).

[148] Dr. Peter Barrett (13:41).

[149] Dr. Peter Barrett (13:7).

[150] Dr. Hugh Scully (13:12).

[151] Dr. Hugh Scully (13:40).

[152] Dr. Peter Barrett (13:9).

[153] Dr. Hugh Scully (13:14).

[154] Dr. Peter Barrett (13:17).

[155] Aiken, Linda et. al., “Nurses Reports on Hospital Care in Five Countries” in Health Affairs, May-June 2001.

[156] Kathleen Connors (13:65).

[157] Canadian Federation of Nurses Unions, Brief to the Committee, 16 May 2001, p. 5.

[158] Régis Paradis (13:50).

[159] Sandra MacDonald-Remecz (13:63).

[160] Kathleen Connors (13:54).

[161] Ibid

[162] Sandra MacDonald-Remecz (13:61).

[163] Dussault, Gilles et. al., The Nursing Labour Market in Canada: Review of the Literature, December 1999, p. 25.

[164] Kathleen Connors (13:55).

[165] Canadian Nurses Association, Brief to the Committee, 16 May 2001, p.4.

[166] Linda Jones (13:46).

[167] Régis Paradis (13:51).

[168] Régis Paradis (13:65).

[169] Kathleen Connors (13:54).

[170] According to Kathleen Connors , 96 per cent of nurses are women (13:65).

[171] Sandra MacDonald-Remecz (13:61).

[172] Sandra MacDonald Remecz (13:61-62).

[173] Kathleen Connors (13:78).

[174] Sandra MacDonald Remecz (13:61).

[175] Canadian Society for Medical Laboratory Science, Brief to the Committee, 26 April 2001, p. 2.

[176] Peartree Solutions Inc., A Situational Analysis of Human Resource Issues in the Pharmacy Profession in Canada, Canadian Pharmacists Association, May 2001 (available at http://www.cdnpharm.ca/).

[177] Dr. Thomas Ward (13:21).

[178] Linda Jones (13:47).

[179] Linda Jones (13:46).

[180] Linda Jones (13:47).

[181] William Tholl (17:18).


PDF FORMAT

The Committee report is available in PDF format (Portable Document Format). These type of electronic documents retain the original look and feel -- complete with text, graphics, photos and colour -- of their printed versions, and can be disseminated independently of computer platform or distribution media.

Acrobat Readers are freely available and enable Windows, Macintosh, DOS and UNIX users to view, navigate through and print any PDF document.

If you need more information on how to use this format or require a reader for your platform, you may wish to visit Adobe Systems Incorporated.


Top of document